AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
143.4|149.7|146.5|8186|All ICCC Groups Combined|55995049|0-14|All Races|Male and Female|1999|||
44.2|47.8|46.0|2573|I Leukemias, myeloproliferative & myelodysplastic diseases|55995049|0-14|All Races|Male and Female|1999|||
34.5|37.7|36.1|2020|I(a) Lymphoid leukemias|55995049|0-14|All Races|Male and Female|1999|||
7.0|8.5|7.7|431|I(b) Acute myeloid leukemias|55995049|0-14|All Races|Male and Female|1999|||
0.4|0.8|0.6|34|I(c) Chronic myeloproliferative diseases|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|55995049|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|78|I(e) Unspecified and other specified leukemias|55995049|0-14|All Races|Male and Female|1999|||
14.5|16.6|15.5|867|II Lymphomas and reticuloendothelial neoplasms|55995049|0-14|All Races|Male and Female|1999|||
4.9|6.2|5.5|308|II(a) Hodgkin lymphomas|55995049|0-14|All Races|Male and Female|1999|||
5.4|6.7|6.0|338|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|55995049|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.5|143|II(c) Burkitt lymphoma|55995049|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|52|II(d) Miscellaneous lymphoreticular neoplasms|55995049|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|26|II(e) Unspecified lymphomas|55995049|0-14|All Races|Male and Female|1999|||
30.2|33.2|31.7|1774|III CNS and misc intracranial and intraspinal neoplasms|55995049|0-14|All Races|Male and Female|1999|||
2.5|3.4|2.9|164|III(a) Ependymomas and choroid plexus tumor|55995049|0-14|All Races|Male and Female|1999|||
13.4|15.4|14.4|804|III(b) Astrocytomas|55995049|0-14|All Races|Male and Female|1999|||
7.2|8.7|7.9|444|III(c) Intracranial and intraspinal embryonal tumors|55995049|0-14|All Races|Male and Female|1999|||
4.6|5.8|5.2|292|III(d) Other gliomas|55995049|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|29|III(e) Other specified intracranial & intraspinal neoplasms|55995049|0-14|All Races|Male and Female|1999|||
0.5|1.0|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|55995049|0-14|All Races|Male and Female|1999|||
9.7|11.4|10.5|585|IV Neuroblastoma and other peripheral nervous cell tumors|55995049|0-14|All Races|Male and Female|1999|||
9.5|11.2|10.4|575|IV(a) Neuroblastoma and ganglioneuroblastoma|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|55995049|0-14|All Races|Male and Female|1999|||
8.6|10.3|9.4|527|IX Soft tissue and other extraosseous sarcomas|55995049|0-14|All Races|Male and Female|1999|||
4.3|5.5|4.9|273|IX(a) Rhabdomyosarcomas|55995049|0-14|All Races|Male and Female|1999|||
0.7|1.3|1.0|54|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|55995049|0-14|All Races|Male and Female|1999|||
2.2|3.1|2.6|147|IX(d) Other specified soft tissue sarcomas|55995049|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|52|IX(e) Unspecified soft tissue sarcomas|55995049|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|Not classified by ICCC|55995049|0-14|All Races|Male and Female|1999|||
3.8|4.9|4.3|239|V Retinoblastoma|55995049|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.1|450|VI Renal tumors|55995049|0-14|All Races|Male and Female|1999|||
6.9|8.4|7.6|424|VI(a) Nephroblastoma and other nonepithelial renal tumors|55995049|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|23|VI(b) Renal carcinomas|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|55995049|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|115|VII Hepatic tumors|55995049|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|93|VII(a) Hepatoblastoma|55995049|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|55995049|0-14|All Races|Male and Female|1999|||
6.6|8.0|7.2|405|VIII Malignant bone tumors|55995049|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|236|VIII(a) Osteosarcomas|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|55995049|0-14|All Races|Male and Female|1999|||
2.0|2.8|2.4|133|VIII(c) Ewing tumor and related sarcomas of bone|55995049|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|55995049|0-14|All Races|Male and Female|1999|||
4.5|5.7|5.0|280|X Germ cell, trophoblastic tumors & neoplasms of gonads|55995049|0-14|All Races|Male and Female|1999|||
1.0|1.7|1.3|74|X(a) Intracranial & intraspinal germ cell tumors|55995049|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.4|75|X(b) Malignant extracranial & extragonadal germ cell tumors|55995049|0-14|All Races|Male and Female|1999|||
1.8|2.6|2.1|119|X(c) Malignant gonadal germ cell tumors|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|55995049|0-14|All Races|Male and Female|1999|||
5.2|6.5|5.8|326|XI Other malignant epithelial neoplasms and malignant melanomas|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|55995049|0-14|All Races|Male and Female|1999|||
1.6|2.3|1.9|107|XI(b) Thyroid carcinomas|55995049|0-14|All Races|Male and Female|1999|||
0.2|0.6|0.4|21|XI(c) Nasopharyngeal carcinomas|55995049|0-14|All Races|Male and Female|1999|||
1.4|2.1|1.7|96|XI(d) Malignant melanomas|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|55995049|0-14|All Races|Male and Female|1999|||
1.2|1.9|1.5|86|XI(f) Other and unspecified carcinomas|55995049|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|XII Other and unspecified malignant neoplasms|55995049|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|55995049|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|55995049|0-14|All Races|Male and Female|1999|||
147.2|153.6|150.4|8445|All ICCC Groups Combined|56294656|0-14|All Races|Male and Female|2000|||
44.5|48.1|46.2|2592|I Leukemias, myeloproliferative & myelodysplastic diseases|56294656|0-14|All Races|Male and Female|2000|||
35.8|39.0|37.4|2094|I(a) Lymphoid leukemias|56294656|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|369|I(b) Acute myeloid leukemias|56294656|0-14|All Races|Male and Female|2000|||
0.6|1.0|0.8|43|I(c) Chronic myeloproliferative diseases|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|56294656|0-14|All Races|Male and Female|2000|||
1.1|1.7|1.4|76|I(e) Unspecified and other specified leukemias|56294656|0-14|All Races|Male and Female|2000|||
15.7|17.9|16.8|946|II Lymphomas and reticuloendothelial neoplasms|56294656|0-14|All Races|Male and Female|2000|||
5.3|6.6|5.9|335|II(a) Hodgkin lymphomas|56294656|0-14|All Races|Male and Female|2000|||
5.4|6.7|6.0|339|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|56294656|0-14|All Races|Male and Female|2000|||
2.4|3.3|2.9|162|II(c) Burkitt lymphoma|56294656|0-14|All Races|Male and Female|2000|||
1.0|1.7|1.3|74|II(d) Miscellaneous lymphoreticular neoplasms|56294656|0-14|All Races|Male and Female|2000|||
0.4|0.9|0.6|36|II(e) Unspecified lymphomas|56294656|0-14|All Races|Male and Female|2000|||
31.8|34.8|33.3|1872|III CNS and misc intracranial and intraspinal neoplasms|56294656|0-14|All Races|Male and Female|2000|||
2.3|3.2|2.7|154|III(a) Ependymomas and choroid plexus tumor|56294656|0-14|All Races|Male and Female|2000|||
16.1|18.2|17.1|963|III(b) Astrocytomas|56294656|0-14|All Races|Male and Female|2000|||
6.9|8.4|7.6|429|III(c) Intracranial and intraspinal embryonal tumors|56294656|0-14|All Races|Male and Female|2000|||
4.1|5.3|4.7|262|III(d) Other gliomas|56294656|0-14|All Races|Male and Female|2000|||
0.3|0.6|0.4|24|III(e) Other specified intracranial & intraspinal neoplasms|56294656|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|40|III(f) Unspecified intracranial and intraspinal neoplasms|56294656|0-14|All Races|Male and Female|2000|||
9.2|10.8|10.0|557|IV Neuroblastoma and other peripheral nervous cell tumors|56294656|0-14|All Races|Male and Female|2000|||
9.0|10.7|9.9|550|IV(a) Neuroblastoma and ganglioneuroblastoma|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|56294656|0-14|All Races|Male and Female|2000|||
9.7|11.4|10.5|591|IX Soft tissue and other extraosseous sarcomas|56294656|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|297|IX(a) Rhabdomyosarcomas|56294656|0-14|All Races|Male and Female|2000|||
0.7|1.2|0.9|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|56294656|0-14|All Races|Male and Female|2000|||
2.7|3.7|3.2|180|IX(d) Other specified soft tissue sarcomas|56294656|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|60|IX(e) Unspecified soft tissue sarcomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|56294656|0-14|All Races|Male and Female|2000|||
3.9|5.0|4.4|246|V Retinoblastoma|56294656|0-14|All Races|Male and Female|2000|||
8.0|9.6|8.8|490|VI Renal tumors|56294656|0-14|All Races|Male and Female|2000|||
7.6|9.2|8.4|467|VI(a) Nephroblastoma and other nonepithelial renal tumors|56294656|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|56294656|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|123|VII Hepatic tumors|56294656|0-14|All Races|Male and Female|2000|||
1.6|2.4|2.0|110|VII(a) Hepatoblastoma|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|56294656|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|373|VIII Malignant bone tumors|56294656|0-14|All Races|Male and Female|2000|||
3.1|4.1|3.6|203|VIII(a) Osteosarcomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|56294656|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|151|VIII(c) Ewing tumor and related sarcomas of bone|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|56294656|0-14|All Races|Male and Female|2000|||
4.4|5.5|4.9|277|X Germ cell, trophoblastic tumors & neoplasms of gonads|56294656|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|81|X(a) Intracranial & intraspinal germ cell tumors|56294656|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|61|X(b) Malignant extracranial & extragonadal germ cell tumors|56294656|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|124|X(c) Malignant gonadal germ cell tumors|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|56294656|0-14|All Races|Male and Female|2000|||
5.1|6.3|5.7|321|XI Other malignant epithelial neoplasms and malignant melanomas|56294656|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|56294656|0-14|All Races|Male and Female|2000|||
1.5|2.2|1.8|103|XI(b) Thyroid carcinomas|56294656|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|56294656|0-14|All Races|Male and Female|2000|||
1.4|2.1|1.7|98|XI(d) Malignant melanomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|56294656|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|81|XI(f) Other and unspecified carcinomas|56294656|0-14|All Races|Male and Female|2000|||
0.6|1.1|0.8|44|XII Other and unspecified malignant neoplasms|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|56294656|0-14|All Races|Male and Female|2000|||
0.4|0.8|0.6|31|XII(b) Other unspecified malignant tumors|56294656|0-14|All Races|Male and Female|2000|||
153.8|160.3|157.0|8973|All ICCC Groups Combined|57180220|0-14|All Races|Male and Female|2001|||
49.1|52.9|51.0|2897|I Leukemias, myeloproliferative & myelodysplastic diseases|57180220|0-14|All Races|Male and Female|2001|||
37.5|40.7|39.1|2215|I(a) Lymphoid leukemias|57180220|0-14|All Races|Male and Female|2001|||
6.7|8.1|7.4|423|I(b) Acute myeloid leukemias|57180220|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.6|94|I(c) Chronic myeloproliferative diseases|57180220|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57180220|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.2|70|I(e) Unspecified and other specified leukemias|57180220|0-14|All Races|Male and Female|2001|||
15.1|17.2|16.1|926|II Lymphomas and reticuloendothelial neoplasms|57180220|0-14|All Races|Male and Female|2001|||
5.3|6.5|5.9|339|II(a) Hodgkin lymphomas|57180220|0-14|All Races|Male and Female|2001|||
5.9|7.2|6.5|376|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57180220|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|129|II(c) Burkitt lymphoma|57180220|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|58|II(d) Miscellaneous lymphoreticular neoplasms|57180220|0-14|All Races|Male and Female|2001|||
0.3|0.6|0.4|24|II(e) Unspecified lymphomas|57180220|0-14|All Races|Male and Female|2001|||
31.4|34.4|32.8|1873|III CNS and misc intracranial and intraspinal neoplasms|57180220|0-14|All Races|Male and Female|2001|||
2.4|3.2|2.8|158|III(a) Ependymomas and choroid plexus tumor|57180220|0-14|All Races|Male and Female|2001|||
15.3|17.4|16.3|930|III(b) Astrocytomas|57180220|0-14|All Races|Male and Female|2001|||
6.6|8.0|7.3|416|III(c) Intracranial and intraspinal embryonal tumors|57180220|0-14|All Races|Male and Female|2001|||
4.8|6.1|5.4|310|III(d) Other gliomas|57180220|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.7|38|III(e) Other specified intracranial & intraspinal neoplasms|57180220|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|21|III(f) Unspecified intracranial and intraspinal neoplasms|57180220|0-14|All Races|Male and Female|2001|||
10.9|12.7|11.8|675|IV Neuroblastoma and other peripheral nervous cell tumors|57180220|0-14|All Races|Male and Female|2001|||
10.8|12.6|11.7|668|IV(a) Neuroblastoma and ganglioneuroblastoma|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|57180220|0-14|All Races|Male and Female|2001|||
9.6|11.3|10.5|600|IX Soft tissue and other extraosseous sarcomas|57180220|0-14|All Races|Male and Female|2001|||
4.6|5.8|5.2|293|IX(a) Rhabdomyosarcomas|57180220|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|73|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|57180220|0-14|All Races|Male and Female|2001|||
2.6|3.6|3.1|177|IX(d) Other specified soft tissue sarcomas|57180220|0-14|All Races|Male and Female|2001|||
0.7|1.3|1.0|57|IX(e) Unspecified soft tissue sarcomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|57180220|0-14|All Races|Male and Female|2001|||
3.9|5.0|4.5|256|V Retinoblastoma|57180220|0-14|All Races|Male and Female|2001|||
7.9|9.4|8.6|488|VI Renal tumors|57180220|0-14|All Races|Male and Female|2001|||
7.5|9.0|8.2|467|VI(a) Nephroblastoma and other nonepithelial renal tumors|57180220|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|57180220|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|VII Hepatic tumors|57180220|0-14|All Races|Male and Female|2001|||
1.4|2.0|1.7|96|VII(a) Hepatoblastoma|57180220|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57180220|0-14|All Races|Male and Female|2001|||
6.2|7.6|6.9|399|VIII Malignant bone tumors|57180220|0-14|All Races|Male and Female|2001|||
3.3|4.3|3.8|218|VIII(a) Osteosarcomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|57180220|0-14|All Races|Male and Female|2001|||
2.3|3.1|2.7|154|VIII(c) Ewing tumor and related sarcomas of bone|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|57180220|0-14|All Races|Male and Female|2001|||
4.5|5.7|5.0|292|X Germ cell, trophoblastic tumors & neoplasms of gonads|57180220|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|74|X(a) Intracranial & intraspinal germ cell tumors|57180220|0-14|All Races|Male and Female|2001|||
1.1|1.7|1.4|81|X(b) Malignant extracranial & extragonadal germ cell tumors|57180220|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|X(c) Malignant gonadal germ cell tumors|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57180220|0-14|All Races|Male and Female|2001|||
6.1|7.5|6.8|392|XI Other malignant epithelial neoplasms and malignant melanomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(a) Adrenocortical carcinomas|57180220|0-14|All Races|Male and Female|2001|||
2.0|2.8|2.4|137|XI(b) Thyroid carcinomas|57180220|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|57180220|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|120|XI(d) Malignant melanomas|57180220|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|57180220|0-14|All Races|Male and Female|2001|||
1.4|2.1|1.7|98|XI(f) Other and unspecified carcinomas|57180220|0-14|All Races|Male and Female|2001|||
0.5|1.0|0.7|41|XII Other and unspecified malignant neoplasms|57180220|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|XII(a) Other specified malignant tumors|57180220|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|57180220|0-14|All Races|Male and Female|2001|||
152.8|159.3|156.0|8919|All ICCC Groups Combined|57184152|0-14|All Races|Male and Female|2002|||
47.9|51.6|49.7|2830|I Leukemias, myeloproliferative & myelodysplastic diseases|57184152|0-14|All Races|Male and Female|2002|||
35.7|38.9|37.3|2118|I(a) Lymphoid leukemias|57184152|0-14|All Races|Male and Female|2002|||
7.2|8.7|7.9|456|I(b) Acute myeloid leukemias|57184152|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|92|I(c) Chronic myeloproliferative diseases|57184152|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|57184152|0-14|All Races|Male and Female|2002|||
1.0|1.6|1.3|72|I(e) Unspecified and other specified leukemias|57184152|0-14|All Races|Male and Female|2002|||
14.6|16.7|15.7|902|II Lymphomas and reticuloendothelial neoplasms|57184152|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.4|312|II(a) Hodgkin lymphomas|57184152|0-14|All Races|Male and Female|2002|||
5.6|6.9|6.2|355|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|57184152|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.8|157|II(c) Burkitt lymphoma|57184152|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.2|66|II(d) Miscellaneous lymphoreticular neoplasms|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|57184152|0-14|All Races|Male and Female|2002|||
33.1|36.2|34.7|1974|III CNS and misc intracranial and intraspinal neoplasms|57184152|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.6|208|III(a) Ependymomas and choroid plexus tumor|57184152|0-14|All Races|Male and Female|2002|||
15.4|17.5|16.5|938|III(b) Astrocytomas|57184152|0-14|All Races|Male and Female|2002|||
6.8|8.2|7.5|424|III(c) Intracranial and intraspinal embryonal tumors|57184152|0-14|All Races|Male and Female|2002|||
5.3|6.6|6.0|339|III(d) Other gliomas|57184152|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|57184152|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|57184152|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.0|630|IV Neuroblastoma and other peripheral nervous cell tumors|57184152|0-14|All Races|Male and Female|2002|||
10.1|11.8|10.9|622|IV(a) Neuroblastoma and ganglioneuroblastoma|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|57184152|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.0|632|IX Soft tissue and other extraosseous sarcomas|57184152|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|312|IX(a) Rhabdomyosarcomas|57184152|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.2|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|57184152|0-14|All Races|Male and Female|2002|||
3.0|3.9|3.4|197|IX(d) Other specified soft tissue sarcomas|57184152|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|57184152|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|19|Not classified by ICCC|57184152|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.7|214|V Retinoblastoma|57184152|0-14|All Races|Male and Female|2002|||
7.5|9.0|8.2|468|VI Renal tumors|57184152|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.0|455|VI(a) Nephroblastoma and other nonepithelial renal tumors|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|57184152|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|111|VII Hepatic tumors|57184152|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|90|VII(a) Hepatoblastoma|57184152|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|VII(b) Hepatic carcinomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|57184152|0-14|All Races|Male and Female|2002|||
6.4|7.7|7.0|406|VIII Malignant bone tumors|57184152|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.8|218|VIII(a) Osteosarcomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|57184152|0-14|All Races|Male and Female|2002|||
2.2|3.1|2.6|152|VIII(c) Ewing tumor and related sarcomas of bone|57184152|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|57184152|0-14|All Races|Male and Female|2002|||
4.8|6.1|5.4|314|X Germ cell, trophoblastic tumors & neoplasms of gonads|57184152|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|86|X(a) Intracranial & intraspinal germ cell tumors|57184152|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|87|X(b) Malignant extracranial & extragonadal germ cell tumors|57184152|0-14|All Races|Male and Female|2002|||
1.9|2.7|2.2|130|X(c) Malignant gonadal germ cell tumors|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|57184152|0-14|All Races|Male and Female|2002|||
5.9|7.3|6.6|383|XI Other malignant epithelial neoplasms and malignant melanomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|57184152|0-14|All Races|Male and Female|2002|||
1.6|2.4|2.0|115|XI(b) Thyroid carcinomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|57184152|0-14|All Races|Male and Female|2002|||
2.0|2.8|2.4|136|XI(d) Malignant melanomas|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|57184152|0-14|All Races|Male and Female|2002|||
1.4|2.0|1.7|98|XI(f) Other and unspecified carcinomas|57184152|0-14|All Races|Male and Female|2002|||
0.4|0.9|0.6|36|XII Other and unspecified malignant neoplasms|57184152|0-14|All Races|Male and Female|2002|||
0.2|0.6|0.4|21|XII(a) Other specified malignant tumors|57184152|0-14|All Races|Male and Female|2002|||
~|~|~|~|XII(b) Other unspecified malignant tumors|57184152|0-14|All Races|Male and Female|2002|||
148.8|155.1|151.9|9231|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003|||
45.9|49.4|47.6|2876|I Leukemias, myeloproliferative & myelodysplastic diseases|60628650|0-14|All Races|Male and Female|2003|||
34.4|37.5|35.9|2166|I(a) Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003|||
6.8|8.2|7.5|456|I(b) Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.4|88|I(c) Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|109|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|57|I(e) Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003|||
15.2|17.2|16.2|985|II Lymphomas and reticuloendothelial neoplasms|60628650|0-14|All Races|Male and Female|2003|||
5.3|6.5|5.9|363|II(a) Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|384|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003|||
2.3|3.1|2.7|162|II(c) Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.4|1.1|69|II(d) Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003|||
31.3|34.2|32.8|1982|III CNS and misc intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|III(a) Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003|||
15.3|17.4|16.3|989|III(b) Astrocytomas|60628650|0-14|All Races|Male and Female|2003|||
6.5|7.9|7.2|433|III(c) Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.0|6.2|5.6|337|III(d) Other gliomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.8|51|III(e) Other specified intracranial & intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|III(f) Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003|||
9.9|11.6|10.7|652|IV Neuroblastoma and other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.7|11.4|10.5|642|IV(a) Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003|||
9.7|11.4|10.5|643|IX Soft tissue and other extraosseous sarcomas|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|307|IX(a) Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|62|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003|||
3.0|4.0|3.5|214|IX(d) Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.7|1.2|0.9|58|IX(e) Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|16|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003|||
3.6|4.6|4.1|249|V Retinoblastoma|60628650|0-14|All Races|Male and Female|2003|||
7.8|9.3|8.6|517|VI Renal tumors|60628650|0-14|All Races|Male and Female|2003|||
7.4|8.9|8.1|492|VI(a) Nephroblastoma and other nonepithelial renal tumors|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|21|VI(b) Renal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|152|VII Hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
1.7|2.4|2.0|124|VII(a) Hepatoblastoma|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.5|28|VII(b) Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003|||
6.0|7.3|6.6|407|VIII Malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
3.2|4.2|3.7|227|VIII(a) Osteosarcomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003|||
1.9|2.6|2.2|136|VIII(c) Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|17|VIII(d) Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|312|X Germ cell, trophoblastic tumors & neoplasms of gonads|60628650|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|73|X(a) Intracranial & intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.1|1.8|1.4|87|X(b) Malignant extracranial & extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|136|X(c) Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003|||
5.7|7.0|6.3|393|XI Other malignant epithelial neoplasms and malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.6|2.3|1.9|119|XI(d) Malignant melanomas|60628650|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|60628650|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|113|XI(f) Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003|||
0.6|1.0|0.8|47|XII Other and unspecified malignant neoplasms|60628650|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|27|XII(b) Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003|||
156.6|162.9|159.7|9729|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004|||
49.3|52.9|51.1|3099|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|0-14|All Races|Male and Female|2004|||
37.2|40.3|38.7|2344|I(a) Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(c) Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.9|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|84|I(e) Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004|||
15.1|17.1|16.1|983|II Lymphomas and reticuloendothelial neoplasms|60651802|0-14|All Races|Male and Female|2004|||
4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004|||
6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|148|II(c) Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|II(e) Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004|||
33.5|36.5|34.9|2113|III CNS and misc intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
2.5|3.4|3.0|180|III(a) Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004|||
16.4|18.5|17.4|1055|III(b) Astrocytomas|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|470|III(c) Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004|||
4.8|6.0|5.4|325|III(d) Other gliomas|60651802|0-14|All Races|Male and Female|2004|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|34|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
10.2|11.9|11.0|674|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
10.0|11.6|10.8|661|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
9.8|11.5|10.6|649|IX Soft tissue and other extraosseous sarcomas|60651802|0-14|All Races|Male and Female|2004|||
4.1|5.2|4.7|283|IX(a) Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004|||
3.2|4.2|3.7|225|IX(d) Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004|||
3.8|4.9|4.3|266|V Retinoblastoma|60651802|0-14|All Races|Male and Female|2004|||
7.4|8.9|8.1|494|VI Renal tumors|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004|||
2.3|3.1|2.7|164|VII Hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|144|VII(a) Hepatoblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
6.4|7.8|7.1|435|VIII Malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
3.6|4.6|4.1|252|VIII(a) Osteosarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.7|2.3|143|VIII(c) Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|347|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004|||
6.6|8.0|7.3|447|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.2|3.0|2.6|160|XI(b) Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|153|XI(d) Malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.8|1.4|88|XI(f) Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.5|1.0|0.7|44|XII Other and unspecified malignant neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
152.2|158.5|155.4|9454|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005|||
47.4|50.9|49.1|2983|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|0-14|All Races|Male and Female|2005|||
35.9|39.0|37.4|2267|I(a) Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005|||
6.6|8.0|7.3|444|I(b) Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|86|I(c) Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|99|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.8|1.4|87|I(e) Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005|||
15.6|17.7|16.6|1011|II Lymphomas and reticuloendothelial neoplasms|60519046|0-14|All Races|Male and Female|2005|||
5.3|6.5|5.9|359|II(a) Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005|||
5.8|7.1|6.4|391|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.8|1.5|92|II(d) Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005|||
31.2|34.1|32.7|1973|III CNS and misc intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|200|III(a) Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005|||
15.4|17.4|16.4|990|III(b) Astrocytomas|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|418|III(c) Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005|||
4.5|5.6|5.0|302|III(d) Other gliomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|35|III(e) Other specified intracranial & intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|28|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
11.0|12.7|11.8|726|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
10.8|12.5|11.7|717|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
9.8|11.5|10.6|646|IX Soft tissue and other extraosseous sarcomas|60519046|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.3|321|IX(a) Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|205|IX(d) Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.6|1.1|0.8|49|IX(e) Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|18|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005|||
3.4|4.4|3.9|241|V Retinoblastoma|60519046|0-14|All Races|Male and Female|2005|||
7.5|8.9|8.2|498|VI Renal tumors|60519046|0-14|All Races|Male and Female|2005|||
7.1|8.5|7.8|475|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|145|VII Hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|414|VIII Malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.6|2.2|138|X(c) Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|425|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.8|2.6|2.2|135|XI(b) Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|149|XI(d) Malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|118|XI(f) Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|XII Other and unspecified malignant neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
154.9|161.2|158.0|9618|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006|||
49.6|53.3|51.4|3127|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|0-14|All Races|Male and Female|2006|||
37.2|40.4|38.8|2353|I(a) Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.8|480|I(b) Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.7|105|I(c) Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.7|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|83|I(e) Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006|||
15.7|17.8|16.7|1015|II Lymphomas and reticuloendothelial neoplasms|60516709|0-14|All Races|Male and Female|2006|||
5.5|6.8|6.1|372|II(a) Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006|||
5.8|7.1|6.5|392|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.4|88|II(d) Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006|||
32.3|35.3|33.8|2043|III CNS and misc intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.0|184|III(a) Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006|||
15.2|17.3|16.2|984|III(b) Astrocytomas|60516709|0-14|All Races|Male and Female|2006|||
7.0|8.4|7.7|464|III(c) Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006|||
5.1|6.3|5.6|339|III(d) Other gliomas|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
9.5|11.1|10.3|633|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.4|11.0|10.2|628|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.7|11.3|10.5|638|IX Soft tissue and other extraosseous sarcomas|60516709|0-14|All Races|Male and Female|2006|||
4.3|5.5|4.9|295|IX(a) Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|67|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006|||
3.0|3.9|3.4|209|IX(d) Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.1|252|V Retinoblastoma|60516709|0-14|All Races|Male and Female|2006|||
7.5|9.0|8.2|503|VI Renal tumors|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|160|VII Hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
1.8|2.5|2.1|133|VII(a) Hepatoblastoma|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
6.4|7.7|7.0|425|VIII Malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
3.5|4.5|4.0|242|VIII(a) Osteosarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
4.5|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|92|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|128|X(c) Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006|||
6.8|8.2|7.4|454|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|159|XI(b) Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.0|2.8|2.4|147|XI(d) Malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|111|XI(f) Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.8|46|XII Other and unspecified malignant neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
158.4|164.8|161.6|9875|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007|||
50.2|53.8|52.0|3174|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|0-14|All Races|Male and Female|2007|||
38.4|41.6|40.0|2434|I(a) Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|472|I(b) Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007|||
1.3|2.0|1.6|101|I(c) Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|72|I(e) Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007|||
15.6|17.7|16.6|1009|II Lymphomas and reticuloendothelial neoplasms|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.0|5.4|329|II(a) Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007|||
6.4|7.7|7.0|425|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|161|II(c) Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|81|II(d) Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007|||
33.5|36.5|35.0|2125|III CNS and misc intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
2.5|3.4|2.9|177|III(a) Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007|||
15.6|17.7|16.6|1010|III(b) Astrocytomas|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|468|III(c) Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.5|393|III(d) Other gliomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
10.9|12.6|11.8|734|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.7|12.4|11.6|722|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.2|11.9|11.0|674|IX Soft tissue and other extraosseous sarcomas|60681615|0-14|All Races|Male and Female|2007|||
5.1|6.4|5.7|349|IX(a) Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.4|1.1|71|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007|||
2.9|3.8|3.3|202|IX(d) Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.8|51|IX(e) Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007|||
3.7|4.8|4.2|266|V Retinoblastoma|60681615|0-14|All Races|Male and Female|2007|||
7.9|9.4|8.6|528|VI Renal tumors|60681615|0-14|All Races|Male and Female|2007|||
7.5|8.9|8.1|501|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|159|VII Hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.3|141|VII(a) Hepatoblastoma|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|VII(b) Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
6.2|7.5|6.8|412|VIII Malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.7|221|VIII(a) Osteosarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|16|VIII(d) Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|337|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|85|X(a) Intracranial & intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007|||
6.0|7.3|6.7|405|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.7|2.2|137|XI(b) Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|132|XI(d) Malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.4|2.1|1.7|103|XI(f) Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
160.7|167.2|163.9|10059|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008|||
52.0|55.7|53.9|3306|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|0-14|All Races|Male and Female|2008|||
39.4|42.6|41.0|2514|I(a) Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008|||
7.3|8.7|8.0|491|I(b) Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008|||
1.7|2.5|2.1|129|I(c) Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
1.4|2.0|1.7|103|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.4|1.1|69|I(e) Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008|||
16.1|18.2|17.1|1037|II Lymphomas and reticuloendothelial neoplasms|60907384|0-14|All Races|Male and Female|2008|||
5.7|6.9|6.3|380|II(a) Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008|||
6.1|7.4|6.7|408|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|162|II(c) Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.5|1.2|73|II(d) Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008|||
33.6|36.6|35.0|2140|III CNS and misc intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|III(a) Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008|||
16.2|18.4|17.3|1053|III(b) Astrocytomas|60907384|0-14|All Races|Male and Female|2008|||
7.4|8.8|8.1|497|III(c) Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008|||
5.3|6.6|5.9|361|III(d) Other gliomas|60907384|0-14|All Races|Male and Female|2008|||
0.5|1.0|0.7|44|III(e) Other specified intracranial & intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.5|0.4|22|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.8|10.9|684|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
9.8|11.5|10.6|667|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.8|11.0|671|IX Soft tissue and other extraosseous sarcomas|60907384|0-14|All Races|Male and Female|2008|||
4.8|5.9|5.3|326|IX(a) Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.7|1.2|0.9|57|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008|||
3.0|3.9|3.4|209|IX(d) Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|78|IX(e) Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.1|0.4|0.3|16|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008|||
3.7|4.7|4.2|263|V Retinoblastoma|60907384|0-14|All Races|Male and Female|2008|||
8.3|9.8|9.0|557|VI Renal tumors|60907384|0-14|All Races|Male and Female|2008|||
7.8|9.3|8.5|530|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|25|VI(b) Renal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|164|VII Hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
6.2|7.5|6.8|413|VIII Malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
3.4|4.4|3.8|231|VIII(a) Osteosarcomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.5|149|VIII(c) Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.9|5.3|324|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|82|X(a) Intracranial & intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|89|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|142|X(c) Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008|||
6.6|8.0|7.3|445|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|138|XI(d) Malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.5|2.3|1.9|114|XI(f) Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
159.2|165.6|162.4|9975|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009|||
50.4|54.0|52.2|3217|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|0-14|All Races|Male and Female|2009|||
39.2|42.4|40.8|2513|I(a) Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009|||
6.6|7.9|7.2|446|I(b) Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.8|1.5|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.4|1.1|70|I(e) Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009|||
15.8|17.9|16.8|1024|II Lymphomas and reticuloendothelial neoplasms|61087581|0-14|All Races|Male and Female|2009|||
5.1|6.4|5.7|347|II(a) Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009|||
6.3|7.7|7.0|424|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|143|II(c) Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009|||
1.3|1.9|1.6|99|II(d) Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|II(e) Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009|||
33.6|36.6|35.1|2150|III CNS and misc intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.5|157|III(a) Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009|||
16.3|18.4|17.3|1059|III(b) Astrocytomas|61087581|0-14|All Races|Male and Female|2009|||
6.9|8.3|7.6|466|III(c) Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.0|7.3|6.6|402|III(d) Other gliomas|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
10.0|11.6|10.8|670|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.8|11.4|10.6|660|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.6|10.7|656|IX Soft tissue and other extraosseous sarcomas|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.0|4.5|274|IX(a) Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009|||
1.0|1.6|1.3|78|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IX(c) Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009|||
3.3|4.3|3.8|231|IX(d) Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|73|IX(e) Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.6|0.4|23|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009|||
4.0|5.0|4.5|280|V Retinoblastoma|61087581|0-14|All Races|Male and Female|2009|||
8.5|10.0|9.2|571|VI Renal tumors|61087581|0-14|All Races|Male and Female|2009|||
7.9|9.3|8.6|533|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009|||
1.9|2.6|2.2|138|VII Hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|117|VII(a) Hepatoblastoma|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
6.4|7.7|7.0|427|VIII Malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
3.5|4.5|4.0|241|VIII(a) Osteosarcomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(b) Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|144|VIII(c) Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
4.9|6.1|5.4|333|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|0-14|All Races|Male and Female|2009|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|73|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.1|2.6|161|X(c) Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(d) Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.5|7.9|7.2|436|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009|||
2.5|3.3|2.9|175|XI(b) Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|25|XI(c) Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.4|2.1|1.7|104|XI(d) Malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(e) Skin carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|113|XI(f) Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.6|1.1|0.8|50|XII Other and unspecified malignant neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|30|XII(b) Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
165.5|168.4|166.9|50755|All ICCC Groups Combined|302940629|0-14|All Races|Male and Female|2009-2013|||
51.5|53.2|52.3|15953|I Leukemias, myeloproliferative & myelodysplastic diseases|302940629|0-14|All Races|Male and Female|2009-2013|||
39.3|40.7|40.0|12195|I(a) Lymphoid leukemias|302940629|0-14|All Races|Male and Female|2009-2013|||
7.2|7.8|7.5|2284|I(b) Acute myeloid leukemias|302940629|0-14|All Races|Male and Female|2009-2013|||
1.5|1.8|1.7|507|I(c) Chronic myeloproliferative diseases|302940629|0-14|All Races|Male and Female|2009-2013|||
1.4|1.7|1.6|473|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|302940629|0-14|All Races|Male and Female|2009-2013|||
1.5|1.8|1.6|494|I(e) Unspecified and other specified leukemias|302940629|0-14|All Races|Male and Female|2009-2013|||
19.3|20.3|19.8|5999|II Lymphomas and reticuloendothelial neoplasms|302940629|0-14|All Races|Male and Female|2009-2013|||
5.2|5.7|5.5|1644|II(a) Hodgkin lymphomas|302940629|0-14|All Races|Male and Female|2009-2013|||
6.8|7.4|7.1|2133|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|302940629|0-14|All Races|Male and Female|2009-2013|||
2.2|2.6|2.4|728|II(c) Burkitt lymphoma|302940629|0-14|All Races|Male and Female|2009-2013|||
4.4|4.9|4.7|1425|II(d) Miscellaneous lymphoreticular neoplasms|302940629|0-14|All Races|Male and Female|2009-2013|||
0.2|0.3|0.2|69|II(e) Unspecified lymphomas|302940629|0-14|All Races|Male and Female|2009-2013|||
34.4|35.7|35.0|10635|III CNS and misc intracranial and intraspinal neoplasms|302940629|0-14|All Races|Male and Female|2009-2013|||
2.8|3.2|3.0|922|III(a) Ependymomas and choroid plexus tumor|302940629|0-14|All Races|Male and Female|2009-2013|||
17.4|18.3|17.8|5413|III(b) Astrocytomas|302940629|0-14|All Races|Male and Female|2009-2013|||
6.9|7.5|7.2|2181|III(c) Intracranial and intraspinal embryonal tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
5.6|6.2|5.9|1788|III(d) Other gliomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.5|0.7|0.6|177|III(e) Other specified intracranial & intraspinal neoplasms|302940629|0-14|All Races|Male and Female|2009-2013|||
0.4|0.6|0.5|154|III(f) Unspecified intracranial and intraspinal neoplasms|302940629|0-14|All Races|Male and Female|2009-2013|||
10.9|11.7|11.3|3456|IV Neuroblastoma and other peripheral nervous cell tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
10.7|11.5|11.1|3395|IV(a) Neuroblastoma and ganglioneuroblastoma|302940629|0-14|All Races|Male and Female|2009-2013|||
0.2|0.3|0.2|61|IV(b) Other peripheral nervous cell tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
10.7|11.4|11.0|3350|IX Soft tissue and other extraosseous sarcomas|302940629|0-14|All Races|Male and Female|2009-2013|||
4.8|5.4|5.1|1549|IX(a) Rhabdomyosarcomas|302940629|0-14|All Races|Male and Female|2009-2013|||
1.0|1.2|1.1|327|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|302940629|0-14|All Races|Male and Female|2009-2013|||
~|~|~|~|IX(c) Kaposi sarcoma|302940629|0-14|All Races|Male and Female|2009-2013|||
3.5|3.9|3.7|1120|IX(d) Other specified soft tissue sarcomas|302940629|0-14|All Races|Male and Female|2009-2013|||
1.0|1.3|1.1|347|IX(e) Unspecified soft tissue sarcomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.2|0.3|0.3|85|Not classified by ICCC|302940629|0-14|All Races|Male and Female|2009-2013|||
4.1|4.6|4.3|1335|V Retinoblastoma|302940629|0-14|All Races|Male and Female|2009-2013|||
8.5|9.2|8.8|2701|VI Renal tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
8.0|8.7|8.4|2565|VI(a) Nephroblastoma and other nonepithelial renal tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
0.3|0.5|0.4|122|VI(b) Renal carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
2.7|3.1|2.9|885|VII Hepatic tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
2.3|2.6|2.4|753|VII(a) Hepatoblastoma|302940629|0-14|All Races|Male and Female|2009-2013|||
0.3|0.5|0.4|123|VII(b) Hepatic carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
6.8|7.4|7.1|2144|VIII Malignant bone tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
3.7|4.2|4.0|1195|VIII(a) Osteosarcomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.1|0.2|0.2|46|VIII(b) Chondrosarcomas|302940629|0-14|All Races|Male and Female|2009-2013|||
2.3|2.7|2.5|759|VIII(c) Ewing tumor and related sarcomas of bone|302940629|0-14|All Races|Male and Female|2009-2013|||
0.3|0.4|0.3|101|VIII(d) Other specified malignant bone tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
0.1|0.2|0.1|43|VIII(e) Unspecified malignant bone tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
5.2|5.8|5.5|1665|X Germ cell, trophoblastic tumors & neoplasms of gonads|302940629|0-14|All Races|Male and Female|2009-2013|||
1.4|1.7|1.6|471|X(a) Intracranial & intraspinal germ cell tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
1.2|1.4|1.3|391|X(b) Malignant extracranial & extragonadal germ cell tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
2.2|2.5|2.4|716|X(c) Malignant gonadal germ cell tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
0.1|0.2|0.1|35|X(d) Gonadal carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.1|0.2|0.2|52|X(e) Other and unspecified malignant gonadal tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
7.4|8.1|7.7|2332|XI Other malignant epithelial neoplasms and malignant melanomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.2|0.3|0.2|68|XI(a) Adrenocortical carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
3.0|3.4|3.2|958|XI(b) Thyroid carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.3|0.4|0.3|98|XI(c) Nasopharyngeal carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
1.8|2.1|2.0|591|XI(d) Malignant melanomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.0|0.1|0.1|16|XI(e) Skin carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
1.8|2.2|2.0|601|XI(f) Other and unspecified carcinomas|302940629|0-14|All Races|Male and Female|2009-2013|||
0.6|0.8|0.7|215|XII Other and unspecified malignant neoplasms|302940629|0-14|All Races|Male and Female|2009-2013|||
0.3|0.4|0.3|106|XII(a) Other specified malignant tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
0.3|0.4|0.4|109|XII(b) Other unspecified malignant tumors|302940629|0-14|All Races|Male and Female|2009-2013|||
165.9|172.4|169.1|10400|All ICCC Groups Combined|61202418|0-14|All Races|Male and Female|2010|||
52.3|56.0|54.1|3337|I Leukemias, myeloproliferative & myelodysplastic diseases|61202418|0-14|All Races|Male and Female|2010|||
39.3|42.5|40.8|2520|I(a) Lymphoid leukemias|61202418|0-14|All Races|Male and Female|2010|||
7.1|8.5|7.7|476|I(b) Acute myeloid leukemias|61202418|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|117|I(c) Chronic myeloproliferative diseases|61202418|0-14|All Races|Male and Female|2010|||
1.6|2.3|1.9|119|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61202418|0-14|All Races|Male and Female|2010|||
1.4|2.1|1.7|105|I(e) Unspecified and other specified leukemias|61202418|0-14|All Races|Male and Female|2010|||
18.8|21.1|19.9|1218|II Lymphomas and reticuloendothelial neoplasms|61202418|0-14|All Races|Male and Female|2010|||
4.8|5.9|5.3|323|II(a) Hodgkin lymphomas|61202418|0-14|All Races|Male and Female|2010|||
6.5|7.9|7.2|439|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61202418|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|61202418|0-14|All Races|Male and Female|2010|||
4.3|5.4|4.8|295|II(d) Miscellaneous lymphoreticular neoplasms|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|II(e) Unspecified lymphomas|61202418|0-14|All Races|Male and Female|2010|||
34.2|37.2|35.6|2188|III CNS and misc intracranial and intraspinal neoplasms|61202418|0-14|All Races|Male and Female|2010|||
2.8|3.7|3.2|201|III(a) Ependymomas and choroid plexus tumor|61202418|0-14|All Races|Male and Female|2010|||
17.0|19.2|18.1|1109|III(b) Astrocytomas|61202418|0-14|All Races|Male and Female|2010|||
6.7|8.1|7.3|452|III(c) Intracranial and intraspinal embryonal tumors|61202418|0-14|All Races|Male and Female|2010|||
5.4|6.6|6.0|364|III(d) Other gliomas|61202418|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.6|39|III(e) Other specified intracranial & intraspinal neoplasms|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|61202418|0-14|All Races|Male and Female|2010|||
10.3|12.0|11.2|693|IV Neuroblastoma and other peripheral nervous cell tumors|61202418|0-14|All Races|Male and Female|2010|||
10.2|11.9|11.0|683|IV(a) Neuroblastoma and ganglioneuroblastoma|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61202418|0-14|All Races|Male and Female|2010|||
10.7|12.4|11.5|706|IX Soft tissue and other extraosseous sarcomas|61202418|0-14|All Races|Male and Female|2010|||
5.0|6.2|5.6|342|IX(a) Rhabdomyosarcomas|61202418|0-14|All Races|Male and Female|2010|||
0.6|1.0|0.8|47|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|IX(c) Kaposi sarcoma|61202418|0-14|All Races|Male and Female|2010|||
3.4|4.4|3.9|238|IX(d) Other specified soft tissue sarcomas|61202418|0-14|All Races|Male and Female|2010|||
1.0|1.6|1.3|79|IX(e) Unspecified soft tissue sarcomas|61202418|0-14|All Races|Male and Female|2010|||
0.1|0.4|0.3|16|Not classified by ICCC|61202418|0-14|All Races|Male and Female|2010|||
3.9|5.0|4.5|277|V Retinoblastoma|61202418|0-14|All Races|Male and Female|2010|||
7.8|9.2|8.5|526|VI Renal tumors|61202418|0-14|All Races|Male and Female|2010|||
7.4|8.8|8.1|504|VI(a) Nephroblastoma and other nonepithelial renal tumors|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61202418|0-14|All Races|Male and Female|2010|||
2.6|3.5|3.0|186|VII Hepatic tumors|61202418|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|156|VII(a) Hepatoblastoma|61202418|0-14|All Races|Male and Female|2010|||
0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61202418|0-14|All Races|Male and Female|2010|||
6.0|7.4|6.7|406|VIII Malignant bone tumors|61202418|0-14|All Races|Male and Female|2010|||
3.2|4.2|3.7|224|VIII(a) Osteosarcomas|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(b) Chondrosarcomas|61202418|0-14|All Races|Male and Female|2010|||
2.0|2.8|2.3|142|VIII(c) Ewing tumor and related sarcomas of bone|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61202418|0-14|All Races|Male and Female|2010|||
5.6|6.8|6.2|377|X Germ cell, trophoblastic tumors & neoplasms of gonads|61202418|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|112|X(a) Intracranial & intraspinal germ cell tumors|61202418|0-14|All Races|Male and Female|2010|||
1.1|1.7|1.3|83|X(b) Malignant extracranial & extragonadal germ cell tumors|61202418|0-14|All Races|Male and Female|2010|||
2.2|3.0|2.6|158|X(c) Malignant gonadal germ cell tumors|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(d) Gonadal carcinomas|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|16|X(e) Other and unspecified malignant gonadal tumors|61202418|0-14|All Races|Male and Female|2010|||
6.4|7.7|7.0|428|XI Other malignant epithelial neoplasms and malignant melanomas|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61202418|0-14|All Races|Male and Female|2010|||
2.4|3.2|2.8|168|XI(b) Thyroid carcinomas|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61202418|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.9|114|XI(d) Malignant melanomas|61202418|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(e) Skin carcinomas|61202418|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|XI(f) Other and unspecified carcinomas|61202418|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|61202418|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|61202418|0-14|All Races|Male and Female|2010|||
165.0|171.6|168.3|10244|All ICCC Groups Combined|60627321|0-14|All Races|Male and Female|2011|||
51.9|55.6|53.7|3278|I Leukemias, myeloproliferative & myelodysplastic diseases|60627321|0-14|All Races|Male and Female|2011|||
39.8|43.1|41.4|2529|I(a) Lymphoid leukemias|60627321|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.6|466|I(b) Acute myeloid leukemias|60627321|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|108|I(c) Chronic myeloproliferative diseases|60627321|0-14|All Races|Male and Female|2011|||
1.1|1.6|1.3|81|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60627321|0-14|All Races|Male and Female|2011|||
1.3|1.9|1.5|94|I(e) Unspecified and other specified leukemias|60627321|0-14|All Races|Male and Female|2011|||
18.9|21.1|20.0|1209|II Lymphomas and reticuloendothelial neoplasms|60627321|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|312|II(a) Hodgkin lymphomas|60627321|0-14|All Races|Male and Female|2011|||
5.8|7.1|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60627321|0-14|All Races|Male and Female|2011|||
2.2|3.0|2.6|157|II(c) Burkitt lymphoma|60627321|0-14|All Races|Male and Female|2011|||
5.0|6.2|5.6|339|II(d) Miscellaneous lymphoreticular neoplasms|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|II(e) Unspecified lymphomas|60627321|0-14|All Races|Male and Female|2011|||
33.5|36.4|34.9|2122|III CNS and misc intracranial and intraspinal neoplasms|60627321|0-14|All Races|Male and Female|2011|||
2.9|3.9|3.4|207|III(a) Ependymomas and choroid plexus tumor|60627321|0-14|All Races|Male and Female|2011|||
16.5|18.6|17.5|1062|III(b) Astrocytomas|60627321|0-14|All Races|Male and Female|2011|||
6.3|7.7|7.0|425|III(c) Intracranial and intraspinal embryonal tumors|60627321|0-14|All Races|Male and Female|2011|||
5.5|6.7|6.1|368|III(d) Other gliomas|60627321|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|60627321|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|30|III(f) Unspecified intracranial and intraspinal neoplasms|60627321|0-14|All Races|Male and Female|2011|||
10.3|12.0|11.1|683|IV Neuroblastoma and other peripheral nervous cell tumors|60627321|0-14|All Races|Male and Female|2011|||
10.1|11.8|10.9|670|IV(a) Neuroblastoma and ganglioneuroblastoma|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60627321|0-14|All Races|Male and Female|2011|||
10.2|11.9|11.0|670|IX Soft tissue and other extraosseous sarcomas|60627321|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|316|IX(a) Rhabdomyosarcomas|60627321|0-14|All Races|Male and Female|2011|||
0.8|1.3|1.0|62|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|IX(c) Kaposi sarcoma|60627321|0-14|All Races|Male and Female|2011|||
3.2|4.2|3.7|224|IX(d) Other specified soft tissue sarcomas|60627321|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|Not classified by ICCC|60627321|0-14|All Races|Male and Female|2011|||
3.7|4.7|4.2|256|V Retinoblastoma|60627321|0-14|All Races|Male and Female|2011|||
8.3|9.8|9.0|555|VI Renal tumors|60627321|0-14|All Races|Male and Female|2011|||
7.9|9.4|8.6|531|VI(a) Nephroblastoma and other nonepithelial renal tumors|60627321|0-14|All Races|Male and Female|2011|||
0.2|0.6|0.4|23|VI(b) Renal carcinomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60627321|0-14|All Races|Male and Female|2011|||
2.7|3.6|3.1|193|VII Hepatic tumors|60627321|0-14|All Races|Male and Female|2011|||
2.3|3.1|2.7|164|VII(a) Hepatoblastoma|60627321|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60627321|0-14|All Races|Male and Female|2011|||
6.7|8.1|7.4|446|VIII Malignant bone tumors|60627321|0-14|All Races|Male and Female|2011|||
3.6|4.7|4.1|248|VIII(a) Osteosarcomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(b) Chondrosarcomas|60627321|0-14|All Races|Male and Female|2011|||
2.4|3.3|2.8|170|VIII(c) Ewing tumor and related sarcomas of bone|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60627321|0-14|All Races|Male and Female|2011|||
4.6|5.7|5.1|310|X Germ cell, trophoblastic tumors & neoplasms of gonads|60627321|0-14|All Races|Male and Female|2011|||
1.2|1.9|1.5|93|X(a) Intracranial & intraspinal germ cell tumors|60627321|0-14|All Races|Male and Female|2011|||
0.9|1.5|1.2|73|X(b) Malignant extracranial & extragonadal germ cell tumors|60627321|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|131|X(c) Malignant gonadal germ cell tumors|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(d) Gonadal carcinomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60627321|0-14|All Races|Male and Female|2011|||
7.1|8.5|7.8|469|XI Other malignant epithelial neoplasms and malignant melanomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60627321|0-14|All Races|Male and Female|2011|||
2.8|3.8|3.3|198|XI(b) Thyroid carcinomas|60627321|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|60627321|0-14|All Races|Male and Female|2011|||
1.8|2.5|2.1|127|XI(d) Malignant melanomas|60627321|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(e) Skin carcinomas|60627321|0-14|All Races|Male and Female|2011|||
1.5|2.2|1.8|108|XI(f) Other and unspecified carcinomas|60627321|0-14|All Races|Male and Female|2011|||
0.5|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60627321|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|60627321|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.4|22|XII(b) Other unspecified malignant tumors|60627321|0-14|All Races|Male and Female|2011|||
163.5|170.0|166.7|10129|All ICCC Groups Combined|60577174|0-14|All Races|Male and Female|2012|||
49.9|53.6|51.7|3150|I Leukemias, myeloproliferative & myelodysplastic diseases|60577174|0-14|All Races|Male and Female|2012|||
38.2|41.3|39.7|2421|I(a) Lymphoid leukemias|60577174|0-14|All Races|Male and Female|2012|||
6.5|7.8|7.1|432|I(b) Acute myeloid leukemias|60577174|0-14|All Races|Male and Female|2012|||
1.2|1.9|1.5|93|I(c) Chronic myeloproliferative diseases|60577174|0-14|All Races|Male and Female|2012|||
1.3|2.0|1.6|99|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60577174|0-14|All Races|Male and Female|2012|||
1.4|2.1|1.7|105|I(e) Unspecified and other specified leukemias|60577174|0-14|All Races|Male and Female|2012|||
20.1|22.5|21.3|1286|II Lymphomas and reticuloendothelial neoplasms|60577174|0-14|All Races|Male and Female|2012|||
5.1|6.3|5.7|341|II(a) Hodgkin lymphomas|60577174|0-14|All Races|Male and Female|2012|||
6.7|8.1|7.4|447|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60577174|0-14|All Races|Male and Female|2012|||
1.9|2.7|2.3|140|II(c) Burkitt lymphoma|60577174|0-14|All Races|Male and Female|2012|||
4.9|6.1|5.5|335|II(d) Miscellaneous lymphoreticular neoplasms|60577174|0-14|All Races|Male and Female|2012|||
0.2|0.6|0.4|23|II(e) Unspecified lymphomas|60577174|0-14|All Races|Male and Female|2012|||
33.1|36.0|34.5|2096|III CNS and misc intracranial and intraspinal neoplasms|60577174|0-14|All Races|Male and Female|2012|||
2.5|3.4|2.9|179|III(a) Ependymomas and choroid plexus tumor|60577174|0-14|All Races|Male and Female|2012|||
17.0|19.2|18.1|1098|III(b) Astrocytomas|60577174|0-14|All Races|Male and Female|2012|||
6.5|7.9|7.2|436|III(c) Intracranial and intraspinal embryonal tumors|60577174|0-14|All Races|Male and Female|2012|||
4.5|5.7|5.1|309|III(d) Other gliomas|60577174|0-14|All Races|Male and Female|2012|||
0.4|0.7|0.5|32|III(e) Other specified intracranial & intraspinal neoplasms|60577174|0-14|All Races|Male and Female|2012|||
0.5|0.9|0.7|42|III(f) Unspecified intracranial and intraspinal neoplasms|60577174|0-14|All Races|Male and Female|2012|||
10.4|12.1|11.2|685|IV Neuroblastoma and other peripheral nervous cell tumors|60577174|0-14|All Races|Male and Female|2012|||
10.2|11.9|11.0|672|IV(a) Neuroblastoma and ganglioneuroblastoma|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60577174|0-14|All Races|Male and Female|2012|||
10.1|11.8|10.9|662|IX Soft tissue and other extraosseous sarcomas|60577174|0-14|All Races|Male and Female|2012|||
4.4|5.6|5.0|303|IX(a) Rhabdomyosarcomas|60577174|0-14|All Races|Male and Female|2012|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|IX(c) Kaposi sarcoma|60577174|0-14|All Races|Male and Female|2012|||
3.1|4.0|3.5|214|IX(d) Other specified soft tissue sarcomas|60577174|0-14|All Races|Male and Female|2012|||
0.9|1.5|1.2|73|IX(e) Unspecified soft tissue sarcomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|Not classified by ICCC|60577174|0-14|All Races|Male and Female|2012|||
3.8|4.9|4.3|264|V Retinoblastoma|60577174|0-14|All Races|Male and Female|2012|||
7.8|9.3|8.5|520|VI Renal tumors|60577174|0-14|All Races|Male and Female|2012|||
7.4|8.8|8.1|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|60577174|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60577174|0-14|All Races|Male and Female|2012|||
2.9|3.8|3.3|202|VII Hepatic tumors|60577174|0-14|All Races|Male and Female|2012|||
2.4|3.3|2.8|173|VII(a) Hepatoblastoma|60577174|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60577174|0-14|All Races|Male and Female|2012|||
6.5|7.9|7.2|433|VIII Malignant bone tumors|60577174|0-14|All Races|Male and Female|2012|||
3.8|4.9|4.4|262|VIII(a) Osteosarcomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(b) Chondrosarcomas|60577174|0-14|All Races|Male and Female|2012|||
1.8|2.6|2.2|133|VIII(c) Ewing tumor and related sarcomas of bone|60577174|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.3|19|VIII(d) Other specified malignant bone tumors|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60577174|0-14|All Races|Male and Female|2012|||
4.5|5.7|5.1|307|X Germ cell, trophoblastic tumors & neoplasms of gonads|60577174|0-14|All Races|Male and Female|2012|||
1.1|1.7|1.4|84|X(a) Intracranial & intraspinal germ cell tumors|60577174|0-14|All Races|Male and Female|2012|||
1.1|1.8|1.4|87|X(b) Malignant extracranial & extragonadal germ cell tumors|60577174|0-14|All Races|Male and Female|2012|||
1.7|2.4|2.0|122|X(c) Malignant gonadal germ cell tumors|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(d) Gonadal carcinomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60577174|0-14|All Races|Male and Female|2012|||
7.0|8.4|7.7|465|XI Other malignant epithelial neoplasms and malignant melanomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60577174|0-14|All Races|Male and Female|2012|||
2.8|3.8|3.3|198|XI(b) Thyroid carcinomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60577174|0-14|All Races|Male and Female|2012|||
1.6|2.4|2.0|119|XI(d) Malignant melanomas|60577174|0-14|All Races|Male and Female|2012|||
~|~|~|~|XI(e) Skin carcinomas|60577174|0-14|All Races|Male and Female|2012|||
1.6|2.3|1.9|117|XI(f) Other and unspecified carcinomas|60577174|0-14|All Races|Male and Female|2012|||
0.6|1.0|0.8|46|XII Other and unspecified malignant neoplasms|60577174|0-14|All Races|Male and Female|2012|||
0.2|0.5|0.4|22|XII(a) Other specified malignant tumors|60577174|0-14|All Races|Male and Female|2012|||
0.3|0.6|0.4|24|XII(b) Other unspecified malignant tumors|60577174|0-14|All Races|Male and Female|2012|||
164.5|171.0|167.7|10172|All ICCC Groups Combined|60552670|0-14|All Races|Male and Female|2013|||
48.3|51.9|50.0|3039|I Leukemias, myeloproliferative & myelodysplastic diseases|60552670|0-14|All Races|Male and Female|2013|||
35.7|38.8|37.2|2262|I(a) Lymphoid leukemias|60552670|0-14|All Races|Male and Female|2013|||
7.1|8.5|7.8|472|I(b) Acute myeloid leukemias|60552670|0-14|All Races|Male and Female|2013|||
1.3|1.9|1.6|95|I(c) Chronic myeloproliferative diseases|60552670|0-14|All Races|Male and Female|2013|||
1.1|1.7|1.4|83|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60552670|0-14|All Races|Male and Female|2013|||
1.7|2.5|2.1|127|I(e) Unspecified and other specified leukemias|60552670|0-14|All Races|Male and Female|2013|||
20.0|22.4|21.2|1282|II Lymphomas and reticuloendothelial neoplasms|60552670|0-14|All Races|Male and Female|2013|||
4.9|6.0|5.4|327|II(a) Hodgkin lymphomas|60552670|0-14|All Races|Male and Female|2013|||
6.6|8.0|7.3|440|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60552670|0-14|All Races|Male and Female|2013|||
2.0|2.7|2.3|141|II(c) Burkitt lymphoma|60552670|0-14|All Races|Male and Female|2013|||
5.3|6.6|5.9|361|II(d) Miscellaneous lymphoreticular neoplasms|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|II(e) Unspecified lymphomas|60552670|0-14|All Races|Male and Female|2013|||
33.3|36.3|34.8|2110|III CNS and misc intracranial and intraspinal neoplasms|60552670|0-14|All Races|Male and Female|2013|||
2.6|3.5|3.0|182|III(a) Ependymomas and choroid plexus tumor|60552670|0-14|All Races|Male and Female|2013|||
17.1|19.3|18.2|1101|III(b) Astrocytomas|60552670|0-14|All Races|Male and Female|2013|||
6.1|7.4|6.8|410|III(c) Intracranial and intraspinal embryonal tumors|60552670|0-14|All Races|Male and Female|2013|||
5.1|6.4|5.7|347|III(d) Other gliomas|60552670|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|60552670|0-14|All Races|Male and Female|2013|||
0.3|0.7|0.5|28|III(f) Unspecified intracranial and intraspinal neoplasms|60552670|0-14|All Races|Male and Female|2013|||
11.1|12.9|12.0|731|IV Neuroblastoma and other peripheral nervous cell tumors|60552670|0-14|All Races|Male and Female|2013|||
10.9|12.6|11.7|715|IV(a) Neuroblastoma and ganglioneuroblastoma|60552670|0-14|All Races|Male and Female|2013|||
0.2|0.4|0.3|16|IV(b) Other peripheral nervous cell tumors|60552670|0-14|All Races|Male and Female|2013|||
10.2|11.8|11.0|665|IX Soft tissue and other extraosseous sarcomas|60552670|0-14|All Races|Male and Female|2013|||
4.7|5.8|5.2|317|IX(a) Rhabdomyosarcomas|60552670|0-14|All Races|Male and Female|2013|||
0.9|1.5|1.2|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|IX(c) Kaposi sarcoma|60552670|0-14|All Races|Male and Female|2013|||
3.1|4.1|3.6|216|IX(d) Other specified soft tissue sarcomas|60552670|0-14|All Races|Male and Female|2013|||
0.7|1.3|1.0|59|IX(e) Unspecified soft tissue sarcomas|60552670|0-14|All Races|Male and Female|2013|||
0.2|0.5|0.3|19|Not classified by ICCC|60552670|0-14|All Races|Male and Female|2013|||
3.8|4.8|4.3|261|V Retinoblastoma|60552670|0-14|All Races|Male and Female|2013|||
8.1|9.6|8.9|540|VI Renal tumors|60552670|0-14|All Races|Male and Female|2013|||
7.7|9.2|8.4|513|VI(a) Nephroblastoma and other nonepithelial renal tumors|60552670|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|24|VI(b) Renal carcinomas|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60552670|0-14|All Races|Male and Female|2013|||
2.4|3.2|2.8|168|VII Hepatic tumors|60552670|0-14|All Races|Male and Female|2013|||
2.0|2.8|2.4|144|VII(a) Hepatoblastoma|60552670|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60552670|0-14|All Races|Male and Female|2013|||
6.6|8.0|7.2|437|VIII Malignant bone tumors|60552670|0-14|All Races|Male and Female|2013|||
3.2|4.2|3.7|222|VIII(a) Osteosarcomas|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(b) Chondrosarcomas|60552670|0-14|All Races|Male and Female|2013|||
2.5|3.3|2.9|173|VIII(c) Ewing tumor and related sarcomas of bone|60552670|0-14|All Races|Male and Female|2013|||
0.3|0.6|0.4|25|VIII(d) Other specified malignant bone tumors|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60552670|0-14|All Races|Male and Female|2013|||
5.1|6.3|5.6|341|X Germ cell, trophoblastic tumors & neoplasms of gonads|60552670|0-14|All Races|Male and Female|2013|||
1.3|2.0|1.6|98|X(a) Intracranial & intraspinal germ cell tumors|60552670|0-14|All Races|Male and Female|2013|||
1.0|1.6|1.3|77|X(b) Malignant extracranial & extragonadal germ cell tumors|60552670|0-14|All Races|Male and Female|2013|||
2.0|2.8|2.4|144|X(c) Malignant gonadal germ cell tumors|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(d) Gonadal carcinomas|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60552670|0-14|All Races|Male and Female|2013|||
8.2|9.7|8.9|539|XI Other malignant epithelial neoplasms and malignant melanomas|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60552670|0-14|All Races|Male and Female|2013|||
3.2|4.2|3.7|220|XI(b) Thyroid carcinomas|60552670|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XI(c) Nasopharyngeal carcinomas|60552670|0-14|All Races|Male and Female|2013|||
1.8|2.5|2.1|129|XI(d) Malignant melanomas|60552670|0-14|All Races|Male and Female|2013|||
~|~|~|~|XI(e) Skin carcinomas|60552670|0-14|All Races|Male and Female|2013|||
2.2|3.0|2.6|154|XI(f) Other and unspecified carcinomas|60552670|0-14|All Races|Male and Female|2013|||
0.5|0.9|0.7|40|XII Other and unspecified malignant neoplasms|60552670|0-14|All Races|Male and Female|2013|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60552670|0-14|All Races|Male and Female|2013|||
0.2|0.4|0.3|17|XII(b) Other unspecified malignant tumors|60552670|0-14|All Races|Male and Female|2013|||
157.0|162.8|159.9|11919|All ICCC Groups Combined|74706728|0-19|All Races|Male and Female|1999|156.7|162.4|159.5
39.8|42.7|41.2|3079|I Leukemias, myeloproliferative & myelodysplastic diseases|74706728|0-19|All Races|Male and Female|1999|39.8|42.7|41.2
29.3|31.9|30.6|2285|I(a) Lymphoid leukemias|74706728|0-19|All Races|Male and Female|1999|29.3|31.9|30.6
7.5|8.9|8.2|609|I(b) Acute myeloid leukemias|74706728|0-19|All Races|Male and Female|1999|7.5|8.8|8.2
0.8|1.3|1.0|75|I(c) Chronic myeloproliferative diseases|74706728|0-19|All Races|Male and Female|1999|0.8|1.3|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74706728|0-19|All Races|Male and Female|1999|~|~|~
1.1|1.6|1.3|99|I(e) Unspecified and other specified leukemias|74706728|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
22.4|24.6|23.5|1752|II Lymphomas and reticuloendothelial neoplasms|74706728|0-19|All Races|Male and Female|1999|22.4|24.6|23.5
11.2|12.8|12.0|893|II(a) Hodgkin lymphomas|74706728|0-19|All Races|Male and Female|1999|11.2|12.8|12.0
7.1|8.4|7.7|576|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74706728|0-19|All Races|Male and Female|1999|7.1|8.4|7.7
2.1|2.8|2.4|183|II(c) Burkitt lymphoma|74706728|0-19|All Races|Male and Female|1999|2.1|2.8|2.4
0.5|0.9|0.7|54|II(d) Miscellaneous lymphoreticular neoplasms|74706728|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
0.5|0.8|0.6|46|II(e) Unspecified lymphomas|74706728|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
27.5|30.0|28.7|2147|III CNS and misc intracranial and intraspinal neoplasms|74706728|0-19|All Races|Male and Female|1999|27.5|30.0|28.7
2.2|3.0|2.6|194|III(a) Ependymomas and choroid plexus tumor|74706728|0-19|All Races|Male and Female|1999|2.2|3.0|2.6
12.7|14.4|13.5|1012|III(b) Astrocytomas|74706728|0-19|All Races|Male and Female|1999|12.7|14.4|13.5
6.1|7.3|6.7|503|III(c) Intracranial and intraspinal embryonal tumors|74706728|0-19|All Races|Male and Female|1999|6.2|7.3|6.7
4.2|5.2|4.7|352|III(d) Other gliomas|74706728|0-19|All Races|Male and Female|1999|4.2|5.2|4.7
0.4|0.7|0.5|38|III(e) Other specified intracranial & intraspinal neoplasms|74706728|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
0.5|0.9|0.6|48|III(f) Unspecified intracranial and intraspinal neoplasms|74706728|0-19|All Races|Male and Female|1999|0.5|0.9|0.6
7.5|8.8|8.2|605|IV Neuroblastoma and other peripheral nervous cell tumors|74706728|0-19|All Races|Male and Female|1999|7.5|8.8|8.1
7.2|8.5|7.9|583|IV(a) Neuroblastoma and ganglioneuroblastoma|74706728|0-19|All Races|Male and Female|1999|7.2|8.5|7.8
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|74706728|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.1|11.6|10.8|809|IX Soft tissue and other extraosseous sarcomas|74706728|0-19|All Races|Male and Female|1999|10.1|11.6|10.8
4.0|5.0|4.5|337|IX(a) Rhabdomyosarcomas|74706728|0-19|All Races|Male and Female|1999|4.0|5.0|4.5
0.9|1.4|1.2|86|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74706728|0-19|All Races|Male and Female|1999|0.9|1.4|1.2
~|~|~|~|IX(c) Kaposi sarcoma|74706728|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|3.9|292|IX(d) Other specified soft tissue sarcomas|74706728|0-19|All Races|Male and Female|1999|3.5|4.4|3.9
1.0|1.5|1.2|91|IX(e) Unspecified soft tissue sarcomas|74706728|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.5|0.3|23|Not classified by ICCC|74706728|0-19|All Races|Male and Female|1999|0.2|0.5|0.3
2.8|3.7|3.2|240|V Retinoblastoma|74706728|0-19|All Races|Male and Female|1999|2.8|3.6|3.2
5.8|7.0|6.4|477|VI Renal tumors|74706728|0-19|All Races|Male and Female|1999|5.8|7.0|6.4
5.3|6.4|5.8|433|VI(a) Nephroblastoma and other nonepithelial renal tumors|74706728|0-19|All Races|Male and Female|1999|5.3|6.4|5.8
0.4|0.7|0.5|40|VI(b) Renal carcinomas|74706728|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|74706728|0-19|All Races|Male and Female|1999|~|~|~
1.7|2.3|2.0|147|VII Hepatic tumors|74706728|0-19|All Races|Male and Female|1999|1.7|2.3|2.0
1.0|1.6|1.3|94|VII(a) Hepatoblastoma|74706728|0-19|All Races|Male and Female|1999|1.0|1.5|1.3
0.5|0.9|0.7|52|VII(b) Hepatic carcinomas|74706728|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74706728|0-19|All Races|Male and Female|1999|~|~|~
8.3|9.6|8.9|665|VIII Malignant bone tumors|74706728|0-19|All Races|Male and Female|1999|8.2|9.6|8.9
4.6|5.7|5.1|383|VIII(a) Osteosarcomas|74706728|0-19|All Races|Male and Female|1999|4.6|5.7|5.1
0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|74706728|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.4|3.1|2.7|204|VIII(c) Ewing tumor and related sarcomas of bone|74706728|0-19|All Races|Male and Female|1999|2.4|3.1|2.7
0.4|0.7|0.5|39|VIII(d) Other specified malignant bone tumors|74706728|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|74706728|0-19|All Races|Male and Female|1999|~|~|~
9.5|11.0|10.3|762|X Germ cell, trophoblastic tumors & neoplasms of gonads|74706728|0-19|All Races|Male and Female|1999|9.5|11.0|10.2
1.2|1.7|1.4|105|X(a) Intracranial & intraspinal germ cell tumors|74706728|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
1.1|1.7|1.4|103|X(b) Malignant extracranial & extragonadal germ cell tumors|74706728|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
6.2|7.4|6.8|503|X(c) Malignant gonadal germ cell tumors|74706728|0-19|All Races|Male and Female|1999|6.2|7.3|6.7
0.3|0.6|0.4|32|X(d) Gonadal carcinomas|74706728|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.2|0.4|0.3|19|X(e) Other and unspecified malignant gonadal tumors|74706728|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
14.6|16.4|15.5|1152|XI Other malignant epithelial neoplasms and malignant melanomas|74706728|0-19|All Races|Male and Female|1999|14.5|16.3|15.4
0.1|0.4|0.2|17|XI(a) Adrenocortical carcinomas|74706728|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.4|6.5|5.9|441|XI(b) Thyroid carcinomas|74706728|0-19|All Races|Male and Female|1999|5.4|6.5|5.9
0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|74706728|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
4.3|5.3|4.8|354|XI(d) Malignant melanomas|74706728|0-19|All Races|Male and Female|1999|4.3|5.3|4.7
~|~|~|~|XI(e) Skin carcinomas|74706728|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|3.9|293|XI(f) Other and unspecified carcinomas|74706728|0-19|All Races|Male and Female|1999|3.5|4.4|3.9
0.6|1.1|0.8|61|XII Other and unspecified malignant neoplasms|74706728|0-19|All Races|Male and Female|1999|0.6|1.0|0.8
0.1|0.4|0.2|17|XII(a) Other specified malignant tumors|74706728|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
0.4|0.8|0.6|44|XII(b) Other unspecified malignant tumors|74706728|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
161.6|167.4|164.5|12350|All ICCC Groups Combined|75211310|0-19|All Races|Male and Female|2000|161.3|167.1|164.2
40.1|43.0|41.5|3113|I Leukemias, myeloproliferative & myelodysplastic diseases|75211310|0-19|All Races|Male and Female|2000|39.9|42.9|41.4
30.8|33.4|32.1|2402|I(a) Lymphoid leukemias|75211310|0-19|All Races|Male and Female|2000|30.7|33.2|31.9
6.5|7.7|7.1|530|I(b) Acute myeloid leukemias|75211310|0-19|All Races|Male and Female|2000|6.5|7.7|7.0
0.7|1.2|0.9|69|I(c) Chronic myeloproliferative diseases|75211310|0-19|All Races|Male and Female|2000|0.7|1.2|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|75211310|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.6|1.3|100|I(e) Unspecified and other specified leukemias|75211310|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
23.9|26.2|25.0|1883|II Lymphomas and reticuloendothelial neoplasms|75211310|0-19|All Races|Male and Female|2000|23.9|26.2|25.0
11.6|13.2|12.3|930|II(a) Hodgkin lymphomas|75211310|0-19|All Races|Male and Female|2000|11.6|13.2|12.4
7.6|8.9|8.2|619|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|75211310|0-19|All Races|Male and Female|2000|7.6|8.9|8.2
2.4|3.1|2.7|207|II(c) Burkitt lymphoma|75211310|0-19|All Races|Male and Female|2000|2.4|3.2|2.8
0.8|1.3|1.0|77|II(d) Miscellaneous lymphoreticular neoplasms|75211310|0-19|All Races|Male and Female|2000|0.8|1.3|1.0
0.5|0.9|0.7|50|II(e) Unspecified lymphomas|75211310|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
29.2|31.7|30.4|2285|III CNS and misc intracranial and intraspinal neoplasms|75211310|0-19|All Races|Male and Female|2000|29.1|31.7|30.4
2.1|2.8|2.4|179|III(a) Ependymomas and choroid plexus tumor|75211310|0-19|All Races|Male and Female|2000|2.0|2.8|2.4
14.9|16.7|15.8|1189|III(b) Astrocytomas|75211310|0-19|All Races|Male and Female|2000|14.9|16.7|15.8
6.0|7.2|6.6|493|III(c) Intracranial and intraspinal embryonal tumors|75211310|0-19|All Races|Male and Female|2000|6.0|7.2|6.6
4.1|5.0|4.5|341|III(d) Other gliomas|75211310|0-19|All Races|Male and Female|2000|4.1|5.0|4.5
0.3|0.6|0.4|33|III(e) Other specified intracranial & intraspinal neoplasms|75211310|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.5|0.9|0.7|50|III(f) Unspecified intracranial and intraspinal neoplasms|75211310|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
7.0|8.2|7.6|566|IV Neuroblastoma and other peripheral nervous cell tumors|75211310|0-19|All Races|Male and Female|2000|6.9|8.2|7.5
6.9|8.1|7.5|557|IV(a) Neuroblastoma and ganglioneuroblastoma|75211310|0-19|All Races|Male and Female|2000|6.8|8.0|7.4
~|~|~|~|IV(b) Other peripheral nervous cell tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
11.3|12.8|12.0|904|IX Soft tissue and other extraosseous sarcomas|75211310|0-19|All Races|Male and Female|2000|11.2|12.8|12.0
4.4|5.4|4.9|369|IX(a) Rhabdomyosarcomas|75211310|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
1.0|1.5|1.2|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|75211310|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|75211310|0-19|All Races|Male and Female|2000|~|~|~
4.0|5.0|4.5|337|IX(d) Other specified soft tissue sarcomas|75211310|0-19|All Races|Male and Female|2000|4.0|5.0|4.5
1.1|1.7|1.4|104|IX(e) Unspecified soft tissue sarcomas|75211310|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
0.1|0.3|0.2|16|Not classified by ICCC|75211310|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
2.9|3.8|3.3|247|V Retinoblastoma|75211310|0-19|All Races|Male and Female|2000|2.9|3.7|3.3
6.3|7.5|6.8|511|VI Renal tumors|75211310|0-19|All Races|Male and Female|2000|6.2|7.4|6.8
5.8|6.9|6.3|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|75211310|0-19|All Races|Male and Female|2000|5.7|6.9|6.3
0.3|0.7|0.5|37|VI(b) Renal carcinomas|75211310|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
1.5|2.2|1.8|137|VII Hepatic tumors|75211310|0-19|All Races|Male and Female|2000|1.5|2.2|1.8
1.2|1.8|1.5|110|VII(a) Hepatoblastoma|75211310|0-19|All Races|Male and Female|2000|1.2|1.8|1.5
0.2|0.5|0.4|27|VII(b) Hepatic carcinomas|75211310|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
7.8|9.2|8.5|639|VIII Malignant bone tumors|75211310|0-19|All Races|Male and Female|2000|7.9|9.2|8.5
4.3|5.3|4.8|359|VIII(a) Osteosarcomas|75211310|0-19|All Races|Male and Female|2000|4.3|5.3|4.8
~|~|~|~|VIII(b) Chondrosarcomas|75211310|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.5|3.1|233|VIII(c) Ewing tumor and related sarcomas of bone|75211310|0-19|All Races|Male and Female|2000|2.7|3.5|3.1
0.1|0.4|0.2|18|VIII(d) Other specified malignant bone tumors|75211310|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|75211310|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
10.0|11.5|10.7|808|X Germ cell, trophoblastic tumors & neoplasms of gonads|75211310|0-19|All Races|Male and Female|2000|10.0|11.5|10.7
1.4|2.0|1.6|124|X(a) Intracranial & intraspinal germ cell tumors|75211310|0-19|All Races|Male and Female|2000|1.4|2.0|1.6
1.1|1.7|1.4|104|X(b) Malignant extracranial & extragonadal germ cell tumors|75211310|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.4|7.7|7.0|529|X(c) Malignant gonadal germ cell tumors|75211310|0-19|All Races|Male and Female|2000|6.4|7.7|7.0
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|75211310|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|75211310|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
14.7|16.5|15.6|1176|XI Other malignant epithelial neoplasms and malignant melanomas|75211310|0-19|All Races|Male and Female|2000|14.8|16.6|15.6
0.2|0.5|0.3|24|XI(a) Adrenocortical carcinomas|75211310|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.7|426|XI(b) Thyroid carcinomas|75211310|0-19|All Races|Male and Female|2000|5.1|6.2|5.7
0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|75211310|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.6|5.7|5.1|386|XI(d) Malignant melanomas|75211310|0-19|All Races|Male and Female|2000|4.6|5.7|5.1
~|~|~|~|XI(e) Skin carcinomas|75211310|0-19|All Races|Male and Female|2000|~|~|~
3.5|4.4|3.9|294|XI(f) Other and unspecified carcinomas|75211310|0-19|All Races|Male and Female|2000|3.5|4.4|3.9
0.7|1.1|0.9|65|XII Other and unspecified malignant neoplasms|75211310|0-19|All Races|Male and Female|2000|0.7|1.1|0.9
~|~|~|~|XII(a) Other specified malignant tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
0.5|0.9|0.7|50|XII(b) Other unspecified malignant tumors|75211310|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
168.4|174.3|171.4|13110|All ICCC Groups Combined|76516063|0-19|All Races|Male and Female|2001|168.4|174.3|171.3
44.5|47.5|46.0|3500|I Leukemias, myeloproliferative & myelodysplastic diseases|76516063|0-19|All Races|Male and Female|2001|44.2|47.3|45.7
32.0|34.6|33.2|2523|I(a) Lymphoid leukemias|76516063|0-19|All Races|Male and Female|2001|31.7|34.3|33.0
7.1|8.4|7.7|591|I(b) Acute myeloid leukemias|76516063|0-19|All Races|Male and Female|2001|7.1|8.4|7.7
1.9|2.6|2.2|171|I(c) Chronic myeloproliferative diseases|76516063|0-19|All Races|Male and Female|2001|1.9|2.6|2.2
1.3|1.8|1.5|117|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76516063|0-19|All Races|Male and Female|2001|1.3|1.8|1.5
1.0|1.6|1.3|98|I(e) Unspecified and other specified leukemias|76516063|0-19|All Races|Male and Female|2001|1.0|1.6|1.3
23.6|25.9|24.7|1901|II Lymphomas and reticuloendothelial neoplasms|76516063|0-19|All Races|Male and Female|2001|23.7|26.0|24.8
11.8|13.4|12.5|965|II(a) Hodgkin lymphomas|76516063|0-19|All Races|Male and Female|2001|11.8|13.4|12.6
8.1|9.5|8.8|673|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76516063|0-19|All Races|Male and Female|2001|8.1|9.5|8.8
1.8|2.5|2.2|165|II(c) Burkitt lymphoma|76516063|0-19|All Races|Male and Female|2001|1.8|2.5|2.2
0.6|1.0|0.8|60|II(d) Miscellaneous lymphoreticular neoplasms|76516063|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.4|0.7|0.5|38|II(e) Unspecified lymphomas|76516063|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
28.8|31.3|30.1|2294|III CNS and misc intracranial and intraspinal neoplasms|76516063|0-19|All Races|Male and Female|2001|28.8|31.2|30.0
2.1|2.8|2.4|187|III(a) Ependymomas and choroid plexus tumor|76516063|0-19|All Races|Male and Female|2001|2.1|2.8|2.4
14.2|15.9|15.0|1148|III(b) Astrocytomas|76516063|0-19|All Races|Male and Female|2001|14.1|15.9|15.0
6.0|7.2|6.6|501|III(c) Intracranial and intraspinal embryonal tumors|76516063|0-19|All Races|Male and Female|2001|6.0|7.1|6.5
4.5|5.6|5.0|384|III(d) Other gliomas|76516063|0-19|All Races|Male and Female|2001|4.5|5.5|5.0
0.4|0.8|0.6|45|III(e) Other specified intracranial & intraspinal neoplasms|76516063|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
0.3|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|76516063|0-19|All Races|Male and Female|2001|0.3|0.5|0.4
8.4|9.7|9.0|690|IV Neuroblastoma and other peripheral nervous cell tumors|76516063|0-19|All Races|Male and Female|2001|8.4|9.7|9.0
8.2|9.5|8.8|676|IV(a) Neuroblastoma and ganglioneuroblastoma|76516063|0-19|All Races|Male and Female|2001|8.2|9.5|8.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|76516063|0-19|All Races|Male and Female|2001|~|~|~
11.1|12.7|11.9|911|IX Soft tissue and other extraosseous sarcomas|76516063|0-19|All Races|Male and Female|2001|11.1|12.7|11.9
4.5|5.5|5.0|378|IX(a) Rhabdomyosarcomas|76516063|0-19|All Races|Male and Female|2001|4.5|5.5|4.9
1.2|1.7|1.5|112|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76516063|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|76516063|0-19|All Races|Male and Female|2001|~|~|~
3.7|4.7|4.2|321|IX(d) Other specified soft tissue sarcomas|76516063|0-19|All Races|Male and Female|2001|3.7|4.7|4.2
1.0|1.5|1.3|97|IX(e) Unspecified soft tissue sarcomas|76516063|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.2|0.4|0.3|22|Not classified by ICCC|76516063|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
2.9|3.8|3.3|256|V Retinoblastoma|76516063|0-19|All Races|Male and Female|2001|2.9|3.8|3.3
6.2|7.4|6.8|515|VI Renal tumors|76516063|0-19|All Races|Male and Female|2001|6.2|7.3|6.7
5.7|6.8|6.2|471|VI(a) Nephroblastoma and other nonepithelial renal tumors|76516063|0-19|All Races|Male and Female|2001|5.6|6.7|6.2
0.4|0.7|0.5|41|VI(b) Renal carcinomas|76516063|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|76516063|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.1|1.8|138|VII Hepatic tumors|76516063|0-19|All Races|Male and Female|2001|1.5|2.1|1.8
1.0|1.5|1.3|97|VII(a) Hepatoblastoma|76516063|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
0.4|0.7|0.5|40|VII(b) Hepatic carcinomas|76516063|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76516063|0-19|All Races|Male and Female|2001|~|~|~
8.8|10.2|9.5|731|VIII Malignant bone tumors|76516063|0-19|All Races|Male and Female|2001|8.9|10.3|9.6
4.7|5.7|5.2|400|VIII(a) Osteosarcomas|76516063|0-19|All Races|Male and Female|2001|4.7|5.8|5.2
0.2|0.5|0.4|28|VIII(b) Chondrosarcomas|76516063|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.0|3.8|3.4|261|VIII(c) Ewing tumor and related sarcomas of bone|76516063|0-19|All Races|Male and Female|2001|3.0|3.9|3.4
0.3|0.6|0.4|31|VIII(d) Other specified malignant bone tumors|76516063|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|76516063|0-19|All Races|Male and Female|2001|~|~|~
9.7|11.2|10.5|805|X Germ cell, trophoblastic tumors & neoplasms of gonads|76516063|0-19|All Races|Male and Female|2001|9.8|11.3|10.5
1.3|1.9|1.6|123|X(a) Intracranial & intraspinal germ cell tumors|76516063|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|123|X(b) Malignant extracranial & extragonadal germ cell tumors|76516063|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
6.1|7.2|6.6|510|X(c) Malignant gonadal germ cell tumors|76516063|0-19|All Races|Male and Female|2001|6.1|7.3|6.7
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|76516063|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|23|X(e) Other and unspecified malignant gonadal tumors|76516063|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
15.7|17.6|16.6|1280|XI Other malignant epithelial neoplasms and malignant melanomas|76516063|0-19|All Races|Male and Female|2001|15.8|17.7|16.7
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|76516063|0-19|All Races|Male and Female|2001|0.1|0.3|0.2
5.3|6.4|5.9|451|XI(b) Thyroid carcinomas|76516063|0-19|All Races|Male and Female|2001|5.4|6.5|5.9
0.4|0.8|0.6|44|XI(c) Nasopharyngeal carcinomas|76516063|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
5.3|6.4|5.9|451|XI(d) Malignant melanomas|76516063|0-19|All Races|Male and Female|2001|5.4|6.5|5.9
~|~|~|~|XI(e) Skin carcinomas|76516063|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.1|313|XI(f) Other and unspecified carcinomas|76516063|0-19|All Races|Male and Female|2001|3.6|4.6|4.1
0.7|1.1|0.9|67|XII Other and unspecified malignant neoplasms|76516063|0-19|All Races|Male and Female|2001|0.7|1.1|0.9
0.3|0.6|0.4|30|XII(a) Other specified malignant tumors|76516063|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
0.3|0.7|0.5|37|XII(b) Other unspecified malignant tumors|76516063|0-19|All Races|Male and Female|2001|0.3|0.7|0.5
168.4|174.3|171.4|13139|All ICCC Groups Combined|76630713|0-19|All Races|Male and Female|2002|168.5|174.4|171.5
43.6|46.6|45.1|3440|I Leukemias, myeloproliferative & myelodysplastic diseases|76630713|0-19|All Races|Male and Female|2002|43.4|46.4|44.9
30.8|33.3|32.0|2437|I(a) Lymphoid leukemias|76630713|0-19|All Races|Male and Female|2002|30.6|33.1|31.8
7.6|8.9|8.3|636|I(b) Acute myeloid leukemias|76630713|0-19|All Races|Male and Female|2002|7.7|9.0|8.3
1.8|2.4|2.1|162|I(c) Chronic myeloproliferative diseases|76630713|0-19|All Races|Male and Female|2002|1.8|2.5|2.1
1.2|1.8|1.5|116|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76630713|0-19|All Races|Male and Female|2002|1.3|1.8|1.5
0.9|1.4|1.2|89|I(e) Unspecified and other specified leukemias|76630713|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
23.3|25.5|24.4|1880|II Lymphomas and reticuloendothelial neoplasms|76630713|0-19|All Races|Male and Female|2002|23.4|25.7|24.5
11.4|12.9|12.1|941|II(a) Hodgkin lymphomas|76630713|0-19|All Races|Male and Female|2002|11.5|13.1|12.3
7.7|9.0|8.3|638|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76630713|0-19|All Races|Male and Female|2002|7.7|9.0|8.3
2.4|3.1|2.7|208|II(c) Burkitt lymphoma|76630713|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.7|1.1|0.9|67|II(d) Miscellaneous lymphoreticular neoplasms|76630713|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|76630713|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
30.2|32.8|31.5|2403|III CNS and misc intracranial and intraspinal neoplasms|76630713|0-19|All Races|Male and Female|2002|30.1|32.6|31.4
2.6|3.4|3.0|229|III(a) Ependymomas and choroid plexus tumor|76630713|0-19|All Races|Male and Female|2002|2.6|3.4|3.0
14.5|16.3|15.4|1175|III(b) Astrocytomas|76630713|0-19|All Races|Male and Female|2002|14.5|16.2|15.3
5.8|7.0|6.4|487|III(c) Intracranial and intraspinal embryonal tumors|76630713|0-19|All Races|Male and Female|2002|5.8|6.9|6.4
5.1|6.1|5.6|426|III(d) Other gliomas|76630713|0-19|All Races|Male and Female|2002|5.0|6.1|5.6
0.6|0.9|0.7|56|III(e) Other specified intracranial & intraspinal neoplasms|76630713|0-19|All Races|Male and Female|2002|0.6|0.9|0.7
0.3|0.6|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|76630713|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.8|9.1|8.5|646|IV Neuroblastoma and other peripheral nervous cell tumors|76630713|0-19|All Races|Male and Female|2002|7.8|9.1|8.4
7.6|8.9|8.2|627|IV(a) Neuroblastoma and ganglioneuroblastoma|76630713|0-19|All Races|Male and Female|2002|7.6|8.8|8.2
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|76630713|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
11.1|12.7|11.9|914|IX Soft tissue and other extraosseous sarcomas|76630713|0-19|All Races|Male and Female|2002|11.2|12.7|11.9
4.5|5.5|5.0|378|IX(a) Rhabdomyosarcomas|76630713|0-19|All Races|Male and Female|2002|4.4|5.5|4.9
1.0|1.5|1.2|93|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76630713|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|76630713|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.3|4.7|366|IX(d) Other specified soft tissue sarcomas|76630713|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.8|1.2|1.0|77|IX(e) Unspecified soft tissue sarcomas|76630713|0-19|All Races|Male and Female|2002|0.8|1.3|1.0
0.2|0.5|0.3|24|Not classified by ICCC|76630713|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
2.4|3.2|2.8|214|V Retinoblastoma|76630713|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
5.9|7.1|6.5|492|VI Renal tumors|76630713|0-19|All Races|Male and Female|2002|5.9|7.0|6.4
5.5|6.6|6.0|458|VI(a) Nephroblastoma and other nonepithelial renal tumors|76630713|0-19|All Races|Male and Female|2002|5.4|6.5|6.0
0.3|0.6|0.4|33|VI(b) Renal carcinomas|76630713|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
~|~|~|~|VI(c) Unspecified malignant renal tumors|76630713|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|130|VII Hepatic tumors|76630713|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.0|1.5|1.2|91|VII(a) Hepatoblastoma|76630713|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
0.3|0.7|0.5|38|VII(b) Hepatic carcinomas|76630713|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76630713|0-19|All Races|Male and Female|2002|~|~|~
8.5|9.9|9.2|712|VIII Malignant bone tumors|76630713|0-19|All Races|Male and Female|2002|8.6|10.0|9.3
4.4|5.5|4.9|382|VIII(a) Osteosarcomas|76630713|0-19|All Races|Male and Female|2002|4.5|5.5|5.0
0.3|0.7|0.5|37|VIII(b) Chondrosarcomas|76630713|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
2.7|3.6|3.1|241|VIII(c) Ewing tumor and related sarcomas of bone|76630713|0-19|All Races|Male and Female|2002|2.8|3.6|3.1
0.4|0.7|0.5|40|VIII(d) Other specified malignant bone tumors|76630713|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|76630713|0-19|All Races|Male and Female|2002|~|~|~
10.5|12.0|11.2|866|X Germ cell, trophoblastic tumors & neoplasms of gonads|76630713|0-19|All Races|Male and Female|2002|10.6|12.1|11.3
1.4|2.0|1.7|131|X(a) Intracranial & intraspinal germ cell tumors|76630713|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.3|1.9|1.6|124|X(b) Malignant extracranial & extragonadal germ cell tumors|76630713|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.7|7.9|7.3|561|X(c) Malignant gonadal germ cell tumors|76630713|0-19|All Races|Male and Female|2002|6.7|8.0|7.3
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|76630713|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
0.2|0.5|0.3|24|X(e) Other and unspecified malignant gonadal tumors|76630713|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
16.5|18.4|17.4|1348|XI Other malignant epithelial neoplasms and malignant melanomas|76630713|0-19|All Races|Male and Female|2002|16.7|18.6|17.6
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|76630713|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
5.2|6.3|5.7|444|XI(b) Thyroid carcinomas|76630713|0-19|All Races|Male and Female|2002|5.3|6.4|5.8
0.5|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|76630713|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.1|7.3|6.7|516|XI(d) Malignant melanomas|76630713|0-19|All Races|Male and Female|2002|6.2|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|76630713|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|312|XI(f) Other and unspecified carcinomas|76630713|0-19|All Races|Male and Female|2002|3.6|4.5|4.1
0.7|1.1|0.9|70|XII Other and unspecified malignant neoplasms|76630713|0-19|All Races|Male and Female|2002|0.7|1.2|0.9
0.3|0.6|0.5|36|XII(a) Other specified malignant tumors|76630713|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
0.3|0.6|0.4|34|XII(b) Other unspecified malignant tumors|76630713|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
164.4|170.0|167.2|13650|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003|164.8|170.5|167.6
41.9|44.7|43.3|3510|I Leukemias, myeloproliferative & myelodysplastic diseases|81425816|0-19|All Races|Male and Female|2003|41.7|44.6|43.1
29.5|31.9|30.7|2476|I(a) Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003|29.2|31.6|30.4
7.2|8.4|7.8|638|I(b) Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003|7.2|8.5|7.8
1.9|2.5|2.2|181|I(c) Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.9|2.6|2.2
1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003|1.4|1.9|1.6
0.8|1.2|1.0|81|I(e) Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003|0.8|1.2|1.0
23.1|25.3|24.2|1986|II Lymphomas and reticuloendothelial neoplasms|81425816|0-19|All Races|Male and Female|2003|23.3|25.5|24.4
11.7|13.2|12.4|1026|II(a) Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003|11.8|13.4|12.6
7.5|8.7|8.1|660|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003|7.5|8.7|8.1
2.3|3.0|2.6|211|II(c) Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.7|1.1|0.9|72|II(d) Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003|0.7|1.1|0.9
0.1|0.3|0.2|17|II(e) Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
28.8|31.2|30.0|2434|III CNS and misc intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|28.7|31.1|29.9
2.0|2.7|2.3|189|III(a) Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
14.4|16.1|15.3|1240|III(b) Astrocytomas|81425816|0-19|All Races|Male and Female|2003|14.4|16.1|15.2
5.6|6.6|6.1|491|III(c) Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003|5.5|6.6|6.0
4.7|5.7|5.2|420|III(d) Other gliomas|81425816|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.6|1.0|0.8|65|III(e) Other specified intracranial & intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.6|1.0|0.8
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
7.6|8.9|8.2|668|IV Neuroblastoma and other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|7.6|8.9|8.2
7.4|8.7|8.0|653|IV(a) Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003|7.4|8.7|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
11.3|12.9|12.1|989|IX Soft tissue and other extraosseous sarcomas|81425816|0-19|All Races|Male and Female|2003|11.4|12.9|12.1
4.3|5.3|4.8|390|IX(a) Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.2|1.7|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81425816|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003|~|~|~
4.2|5.1|4.6|379|IX(d) Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|4.2|5.1|4.7
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.7|3.5|3.1|250|V Retinoblastoma|81425816|0-19|All Races|Male and Female|2003|2.7|3.5|3.1
6.2|7.3|6.7|544|VI Renal tumors|81425816|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.6|6.7|6.1|495|VI(a) Nephroblastoma and other nonepithelial renal tumors|81425816|0-19|All Races|Male and Female|2003|5.6|6.6|6.1
0.4|0.7|0.5|45|VI(b) Renal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|174|VII Hepatic tumors|81425816|0-19|All Races|Male and Female|2003|1.8|2.5|2.1
1.3|1.8|1.5|124|VII(a) Hepatoblastoma|81425816|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003|~|~|~
8.0|9.3|8.7|714|VIII Malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|8.1|9.4|8.8
4.8|5.8|5.3|436|VIII(a) Osteosarcomas|81425816|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.2|2.9|2.6|212|VIII(c) Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.3|847|X Germ cell, trophoblastic tumors & neoplasms of gonads|81425816|0-19|All Races|Male and Female|2003|9.7|11.1|10.4
1.1|1.6|1.4|113|X(a) Intracranial & intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
6.2|7.3|6.7|554|X(c) Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003|6.2|7.4|6.8
0.2|0.5|0.4|30|X(d) Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
0.3|0.5|0.4|32|X(e) Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.6|0.4
16.3|18.1|17.2|1425|XI Other malignant epithelial neoplasms and malignant melanomas|81425816|0-19|All Races|Male and Female|2003|16.6|18.4|17.5
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003|0.2|0.4|0.2
5.6|6.7|6.1|505|XI(b) Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003|5.7|6.8|6.2
0.5|0.9|0.7|54|XI(c) Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.4|5.9|488|XI(d) Malignant melanomas|81425816|0-19|All Races|Male and Female|2003|5.5|6.5|6.0
~|~|~|~|XI(e) Skin carcinomas|81425816|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.2|349|XI(f) Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003|3.8|4.8|4.3
0.8|1.3|1.1|87|XII Other and unspecified malignant neoplasms|81425816|0-19|All Races|Male and Female|2003|0.9|1.3|1.1
0.3|0.6|0.5|39|XII(a) Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.3|0.7|0.5
0.4|0.8|0.6|48|XII(b) Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
171.1|176.8|173.9|14288|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004|171.9|177.7|174.8
44.6|47.6|46.1|3757|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|0-19|All Races|Male and Female|2004|44.5|47.4|46.0
31.9|34.4|33.2|2694|I(a) Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004|31.7|34.2|33.0
7.6|8.9|8.2|676|I(b) Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004|7.7|8.9|8.3
1.8|2.4|2.1|174|I(c) Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.8|2.5|2.1
1.1|1.6|1.4|112|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.2|101|I(e) Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
23.0|25.2|24.1|1994|II Lymphomas and reticuloendothelial neoplasms|81754354|0-19|All Races|Male and Female|2004|23.3|25.5|24.4
11.1|12.6|11.8|985|II(a) Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004|11.3|12.8|12.0
7.9|9.2|8.5|704|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.4|192|II(c) Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.9|1.3|1.1|87|II(d) Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004|0.9|1.3|1.1
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
30.8|33.2|32.0|2603|III CNS and misc intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|30.6|33.1|31.8
2.4|3.1|2.7|222|III(a) Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.5|17.3|16.4|1335|III(b) Astrocytomas|81754354|0-19|All Races|Male and Female|2004|15.5|17.2|16.3
6.0|7.1|6.6|532|III(c) Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|413|III(d) Other gliomas|81754354|0-19|All Races|Male and Female|2004|4.6|5.6|5.1
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|42|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.8|9.1|8.4|692|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|7.8|9.1|8.5
7.6|8.8|8.2|670|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004|7.6|8.8|8.2
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.9|12.1|996|IX Soft tissue and other extraosseous sarcomas|81754354|0-19|All Races|Male and Female|2004|11.4|13.0|12.2
3.9|4.8|4.3|354|IX(a) Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004|3.9|4.8|4.3
1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|424|IX(d) Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.5|0.3|26|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.9|3.6|3.2|266|V Retinoblastoma|81754354|0-19|All Races|Male and Female|2004|2.9|3.7|3.3
6.0|7.1|6.5|529|VI Renal tumors|81754354|0-19|All Races|Male and Female|2004|5.9|7.0|6.5
5.4|6.5|5.9|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|0-19|All Races|Male and Female|2004|5.3|6.4|5.9
0.4|0.8|0.6|47|VI(b) Renal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.8|2.4|198|VII Hepatic tumors|81754354|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
8.4|9.7|9.0|745|VIII Malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|8.5|9.8|9.1
4.6|5.6|5.1|424|VIII(a) Osteosarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.4|3.1|2.7|226|VIII(c) Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.8
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.8|11.1|924|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|0-19|All Races|Male and Female|2004|10.6|12.1|11.3
1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|110|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.7|7.9|7.3|607|X(c) Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|6.8|8.0|7.4
0.3|0.6|0.4|33|X(d) Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
16.9|18.8|17.8|1486|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|0-19|All Races|Male and Female|2004|17.3|19.1|18.2
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.2|7.4|6.8|565|XI(b) Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004|6.4|7.5|6.9
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.0|6.5|538|XI(d) Malignant melanomas|81754354|0-19|All Races|Male and Female|2004|6.0|7.2|6.6
~|~|~|~|XI(e) Skin carcinomas|81754354|0-19|All Races|Male and Female|2004|~|~|~
3.3|4.2|3.7|310|XI(f) Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004|3.4|4.2|3.8
0.7|1.1|0.9|72|XII Other and unspecified malignant neoplasms|81754354|0-19|All Races|Male and Female|2004|0.7|1.1|0.9
0.2|0.5|0.4|29|XII(a) Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.4
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
169.1|174.8|171.9|14206|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005|170.4|176.1|173.2
43.0|45.9|44.4|3638|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|0-19|All Races|Male and Female|2005|42.9|45.8|44.4
30.8|33.3|32.0|2612|I(a) Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005|30.6|33.1|31.9
6.9|8.1|7.5|622|I(b) Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.7|2.3|2.0|166|I(c) Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.3|1.9|1.6|129|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.1|1.6|1.3|109|I(e) Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005|1.1|1.6|1.3
24.7|26.9|25.8|2150|II Lymphomas and reticuloendothelial neoplasms|82005260|0-19|All Races|Male and Female|2005|25.1|27.4|26.2
11.9|13.5|12.7|1067|II(a) Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005|12.2|13.8|13.0
8.3|9.7|9.0|746|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
2.2|2.9|2.5|205|II(c) Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
1.0|1.5|1.3|103|II(d) Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005|1.0|1.5|1.3
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.4
28.7|31.1|29.9|2436|III CNS and misc intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|28.5|30.9|29.7
2.6|3.3|2.9|241|III(a) Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
14.4|16.1|15.2|1243|III(b) Astrocytomas|82005260|0-19|All Races|Male and Female|2005|14.3|16.0|15.2
5.3|6.4|5.9|475|III(c) Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005|5.3|6.3|5.8
4.3|5.3|4.8|391|III(d) Other gliomas|82005260|0-19|All Races|Male and Female|2005|4.3|5.3|4.8
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.4|35|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
8.4|9.7|9.1|745|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|8.4|9.8|9.1
8.2|9.5|8.8|727|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005|8.2|9.5|8.9
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
11.6|13.1|12.3|1020|IX Soft tissue and other extraosseous sarcomas|82005260|0-19|All Races|Male and Female|2005|11.7|13.2|12.4
4.4|5.4|4.9|400|IX(a) Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|410|IX(d) Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.9|1.3|1.1|89|IX(e) Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|0.9|1.3|1.1
0.2|0.4|0.3|23|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|243|V Retinoblastoma|82005260|0-19|All Races|Male and Female|2005|2.6|3.4|3.0
6.1|7.3|6.7|545|VI Renal tumors|82005260|0-19|All Races|Male and Female|2005|6.1|7.2|6.6
5.5|6.6|6.0|491|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|0-19|All Races|Male and Female|2005|5.5|6.5|6.0
0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|82005260|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.8|734|VIII Malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|8.3|9.6|9.0
4.6|5.5|5.0|418|VIII(a) Osteosarcomas|82005260|0-19|All Races|Male and Female|2005|4.6|5.6|5.1
0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|241|VIII(c) Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.1|11.4|961|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|0-19|All Races|Male and Female|2005|11.0|12.5|11.7
1.3|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
6.9|8.1|7.5|636|X(c) Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|7.2|8.4|7.8
0.2|0.5|0.4|31|X(d) Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.5|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.5|18.3|17.4|1469|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|0-19|All Races|Male and Female|2005|17.0|18.9|17.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
5.6|6.6|6.1|513|XI(b) Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005|5.7|6.8|6.3
0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|548|XI(d) Malignant melanomas|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.2|356|XI(f) Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.9|75|XII Other and unspecified malignant neoplasms|82005260|0-19|All Races|Male and Female|2005|0.7|1.1|0.9
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
169.2|174.9|172.0|14277|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006|170.6|176.3|173.4
45.3|48.2|46.7|3841|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|0-19|All Races|Male and Female|2006|45.2|48.2|46.7
32.0|34.5|33.2|2716|I(a) Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006|31.8|34.3|33.0
7.6|8.8|8.2|679|I(b) Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006|7.6|8.9|8.2
2.0|2.7|2.3|195|I(c) Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.4
1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
1.2|1.7|1.4|117|I(e) Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
23.9|26.1|25.0|2096|II Lymphomas and reticuloendothelial neoplasms|82324418|0-19|All Races|Male and Female|2006|24.4|26.6|25.5
11.7|13.2|12.4|1051|II(a) Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006|12.0|13.6|12.8
8.1|9.4|8.7|726|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006|8.2|9.5|8.8
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
0.9|1.4|1.2|96|II(d) Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006|0.9|1.4|1.2
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
29.8|32.2|30.9|2536|III CNS and misc intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|29.6|32.0|30.8
2.4|3.2|2.8|230|III(a) Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006|2.4|3.2|2.8
14.4|16.1|15.3|1254|III(b) Astrocytomas|82324418|0-19|All Races|Male and Female|2006|14.4|16.1|15.2
5.8|6.9|6.3|515|III(c) Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006|5.7|6.8|6.3
4.9|5.9|5.4|440|III(d) Other gliomas|82324418|0-19|All Races|Male and Female|2006|4.9|5.9|5.3
0.4|0.8|0.6|47|III(e) Other specified intracranial & intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.4|0.8|0.6
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.3|8.5|7.9|649|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|7.3|8.5|7.9
7.1|8.3|7.7|636|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006|7.1|8.3|7.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
10.9|12.4|11.6|964|IX Soft tissue and other extraosseous sarcomas|82324418|0-19|All Races|Male and Female|2006|11.0|12.5|11.7
4.1|5.0|4.6|374|IX(a) Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.0|4.5
1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006|~|~|~
4.0|4.9|4.5|374|IX(d) Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.0|4.5
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.2
0.2|0.4|0.3|24|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
2.7|3.4|3.0|253|V Retinoblastoma|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.1|7.3|6.7|548|VI Renal tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.7
5.5|6.5|6.0|487|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|56|VI(b) Renal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.6|2.3|191|VII Hepatic tumors|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|135|VII(a) Hepatoblastoma|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
8.6|10.0|9.3|775|VIII Malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|8.8|10.1|9.4
4.9|5.9|5.4|449|VIII(a) Osteosarcomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.7|3.4|3.0|252|VIII(c) Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
0.4|0.7|0.5|43|VIII(d) Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
9.5|10.9|10.2|867|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|0-19|All Races|Male and Female|2006|9.8|11.3|10.5
1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
1.2|1.8|1.5|126|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
5.9|6.9|6.4|545|X(c) Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
0.3|0.6|0.5|41|X(d) Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006|0.2|0.5|0.4
16.3|18.1|17.2|1460|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|0-19|All Races|Male and Female|2006|16.8|18.7|17.7
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.1|7.2|6.7|568|XI(b) Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006|6.3|7.5|6.9
0.5|0.8|0.6|55|XI(c) Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
4.9|5.9|5.4|459|XI(d) Malignant melanomas|82324418|0-19|All Races|Male and Female|2006|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82324418|0-19|All Races|Male and Female|2006|~|~|~
3.8|4.6|4.2|355|XI(f) Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006|3.9|4.8|4.3
0.7|1.1|0.9|73|XII Other and unspecified malignant neoplasms|82324418|0-19|All Races|Male and Female|2006|0.7|1.1|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.3|0.5|0.4
173.3|179.0|176.1|14716|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007|175.0|180.7|177.8
45.8|48.7|47.2|3903|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|0-19|All Races|Male and Female|2007|45.7|48.7|47.2
33.0|35.5|34.2|2814|I(a) Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007|32.8|35.3|34.0
7.4|8.6|8.0|665|I(b) Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007|7.4|8.7|8.0
2.1|2.8|2.4|208|I(c) Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
1.2|1.7|1.5|122|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|1.2|1.8|1.5
0.9|1.4|1.1|94|I(e) Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
23.8|26.0|24.9|2100|II Lymphomas and reticuloendothelial neoplasms|82749431|0-19|All Races|Male and Female|2007|24.3|26.5|25.4
11.3|12.8|12.1|1031|II(a) Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007|11.7|13.2|12.5
8.1|9.4|8.7|727|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007|8.2|9.4|8.8
2.3|3.0|2.6|216|II(c) Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
0.9|1.3|1.1|91|II(d) Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.1
0.3|0.6|0.4|35|II(e) Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
30.4|32.8|31.6|2601|III CNS and misc intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|30.2|32.7|31.4
2.2|2.9|2.5|207|III(a) Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
15.0|16.7|15.8|1305|III(b) Astrocytomas|82749431|0-19|All Races|Male and Female|2007|14.9|16.6|15.8
5.9|7.0|6.5|529|III(c) Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.2|6.2|5.7|464|III(d) Other gliomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.6
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
8.4|9.7|9.0|752|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|8.4|9.8|9.1
8.2|9.4|8.8|733|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.9
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
11.8|13.3|12.5|1048|IX Soft tissue and other extraosseous sarcomas|82749431|0-19|All Races|Male and Female|2007|11.9|13.5|12.7
4.7|5.7|5.2|428|IX(a) Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007|4.7|5.7|5.2
1.1|1.6|1.4|116|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.2|4.8|402|IX(d) Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|4.4|5.4|4.9
0.9|1.4|1.2|98|IX(e) Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|1.0|1.4|1.2
0.1|0.3|0.2|18|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
2.8|3.6|3.2|266|V Retinoblastoma|82749431|0-19|All Races|Male and Female|2007|2.8|3.6|3.2
6.3|7.5|6.9|568|VI Renal tumors|82749431|0-19|All Races|Male and Female|2007|6.3|7.5|6.9
5.7|6.8|6.2|512|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|0-19|All Races|Male and Female|2007|5.7|6.7|6.2
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.7|2.3|194|VII Hepatic tumors|82749431|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|82749431|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
8.1|9.4|8.8|733|VIII Malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.9
4.2|5.2|4.7|392|VIII(a) Osteosarcomas|82749431|0-19|All Races|Male and Female|2007|4.3|5.2|4.7
0.3|0.5|0.4|32|VIII(b) Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
2.7|3.5|3.1|257|VIII(c) Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.2|0.5|0.4|30|VIII(d) Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.2|0.4|0.3|22|VIII(e) Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.4|11.8|11.1|951|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|0-19|All Races|Male and Female|2007|10.8|12.2|11.5
1.3|1.9|1.6|134|X(a) Intracranial & intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
6.9|8.1|7.5|643|X(c) Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|7.2|8.4|7.8
0.2|0.5|0.4|31|X(d) Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
0.2|0.4|0.3|25|X(e) Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
16.7|18.5|17.6|1514|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|0-19|All Races|Male and Female|2007|17.4|19.2|18.3
~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
6.7|7.9|7.3|629|XI(b) Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007|7.0|8.2|7.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.4|459|XI(d) Malignant melanomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.5
~|~|~|~|XI(e) Skin carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
3.7|4.5|4.1|351|XI(f) Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007|3.8|4.7|4.2
0.6|1.0|0.8|68|XII Other and unspecified malignant neoplasms|82749431|0-19|All Races|Male and Female|2007|0.6|1.0|0.8
0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.3|0.6|0.5|39|XII(b) Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
175.1|180.8|178.0|14939|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008|176.9|182.6|179.7
47.1|50.1|48.6|4040|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|0-19|All Races|Male and Female|2008|47.1|50.1|48.6
33.8|36.3|35.0|2896|I(a) Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008|33.6|36.1|34.8
7.7|8.9|8.3|696|I(b) Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008|7.8|9.0|8.4
2.3|3.0|2.7|225|I(c) Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|2.4|3.1|2.7
1.3|1.9|1.6|131|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|1.3|1.9|1.6
0.9|1.3|1.1|92|I(e) Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
24.4|26.5|25.4|2152|II Lymphomas and reticuloendothelial neoplasms|83118264|0-19|All Races|Male and Female|2008|24.8|27.0|25.9
12.1|13.7|12.9|1103|II(a) Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008|12.5|14.1|13.3
8.1|9.4|8.8|737|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.9
2.2|2.9|2.5|209|II(c) Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
0.7|1.2|0.9|77|II(d) Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008|0.7|1.2|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
30.7|33.2|31.9|2643|III CNS and misc intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|30.6|33.0|31.8
2.0|2.7|2.4|196|III(a) Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008|2.0|2.7|2.4
15.2|17.0|16.1|1330|III(b) Astrocytomas|83118264|0-19|All Races|Male and Female|2008|15.2|16.9|16.0
6.1|7.3|6.7|553|III(c) Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008|6.1|7.2|6.7
5.2|6.2|5.7|472|III(d) Other gliomas|83118264|0-19|All Races|Male and Female|2008|5.2|6.2|5.7
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.6|0.4|33|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
7.8|9.0|8.4|702|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|7.8|9.1|8.4
7.5|8.7|8.1|675|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008|7.5|8.8|8.1
0.2|0.5|0.3|27|IV(b) Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
11.5|13.0|12.3|1029|IX Soft tissue and other extraosseous sarcomas|83118264|0-19|All Races|Male and Female|2008|11.6|13.2|12.4
4.6|5.6|5.1|425|IX(a) Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
0.9|1.3|1.1|91|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|0-19|All Races|Male and Female|2008|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.6|385|IX(d) Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|4.2|5.1|4.6
1.2|1.8|1.5|126|IX(e) Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|1.3|1.8|1.5
0.2|0.4|0.3|23|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.7|3.5|3.1|263|V Retinoblastoma|83118264|0-19|All Races|Male and Female|2008|2.8|3.6|3.2
6.7|7.8|7.2|601|VI Renal tumors|83118264|0-19|All Races|Male and Female|2008|6.7|7.8|7.2
5.9|7.0|6.5|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|0-19|All Races|Male and Female|2008|5.9|7.0|6.4
0.6|0.9|0.7|63|VI(b) Renal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.6|2.3|190|VII Hepatic tumors|83118264|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
8.1|9.4|8.7|732|VIII Malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.8
4.5|5.4|4.9|413|VIII(a) Osteosarcomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
0.3|0.5|0.4|32|VIII(d) Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.2|0.4|0.2|21|VIII(e) Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
10.2|11.6|10.9|941|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|0-19|All Races|Male and Female|2008|10.6|12.1|11.3
1.5|2.0|1.7|145|X(a) Intracranial & intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.5|2.1|1.7
1.2|1.7|1.4|123|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
6.7|7.9|7.3|631|X(c) Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|7.0|8.2|7.6
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
17.2|19.0|18.1|1560|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|0-19|All Races|Male and Female|2008|17.8|19.7|18.8
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
7.4|8.6|8.0|694|XI(b) Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008|7.7|9.0|8.3
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.4|5.4|4.9|418|XI(d) Malignant melanomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.5|5.0
~|~|~|~|XI(e) Skin carcinomas|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.0|4.9|4.4|378|XI(f) Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008|4.1|5.0|4.5
0.6|1.0|0.7|63|XII Other and unspecified malignant neoplasms|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.2|0.5|0.4|31|XII(b) Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
174.1|179.8|177.0|14866|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009|175.6|181.4|178.5
45.6|48.5|47.0|3918|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|0-19|All Races|Male and Female|2009|45.6|48.5|47.0
33.2|35.8|34.5|2863|I(a) Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009|33.1|35.7|34.4
7.0|8.2|7.6|639|I(b) Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009|7.1|8.3|7.7
2.0|2.6|2.3|194|I(c) Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|2.0|2.7|2.3
1.2|1.8|1.5|125|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|1.2|1.8|1.5
0.9|1.4|1.2|97|I(e) Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009|0.9|1.4|1.2
24.2|26.3|25.2|2139|II Lymphomas and reticuloendothelial neoplasms|83280391|0-19|All Races|Male and Female|2009|24.6|26.8|25.7
11.8|13.4|12.6|1079|II(a) Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009|12.2|13.8|13.0
8.2|9.5|8.8|743|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009|8.3|9.6|8.9
1.9|2.6|2.2|184|II(c) Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009|1.9|2.6|2.2
1.1|1.6|1.3|108|II(d) Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.3
0.2|0.4|0.3|25|II(e) Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
30.5|33.0|31.7|2630|III CNS and misc intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|30.4|32.8|31.6
2.1|2.8|2.4|204|III(a) Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.4
15.1|16.8|15.9|1323|III(b) Astrocytomas|83280391|0-19|All Races|Male and Female|2009|15.0|16.8|15.9
5.8|6.9|6.3|523|III(c) Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009|5.8|6.8|6.3
5.5|6.5|6.0|493|III(d) Other gliomas|83280391|0-19|All Races|Male and Female|2009|5.4|6.5|5.9
0.4|0.8|0.6|48|III(e) Other specified intracranial & intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.3|0.6|0.5
7.6|8.9|8.2|685|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|7.6|8.9|8.2
7.4|8.6|8.0|665|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009|7.4|8.6|8.0
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.4|0.2
11.4|12.9|12.1|1018|IX Soft tissue and other extraosseous sarcomas|83280391|0-19|All Races|Male and Female|2009|11.5|13.0|12.2
3.8|4.7|4.2|352|IX(a) Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009|3.8|4.7|4.2
1.3|1.8|1.5|130|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|0-19|All Races|Male and Female|2009|1.3|1.9|1.6
~|~|~|~|IX(c) Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.5|5.4|4.9|415|IX(d) Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|4.5|5.5|5.0
1.1|1.6|1.4|114|IX(e) Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.4
0.3|0.5|0.4|31|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009|0.3|0.5|0.4
3.0|3.8|3.4|280|V Retinoblastoma|83280391|0-19|All Races|Male and Female|2009|3.0|3.8|3.4
6.8|8.0|7.3|612|VI Renal tumors|83280391|0-19|All Races|Male and Female|2009|6.8|8.0|7.3
6.0|7.1|6.5|543|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|0-19|All Races|Male and Female|2009|6.0|7.1|6.5
0.6|1.0|0.8|67|VI(b) Renal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
1.7|2.3|2.0|168|VII Hepatic tumors|83280391|0-19|All Races|Male and Female|2009|1.7|2.3|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
8.4|9.7|9.0|755|VIII Malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|8.4|9.7|9.1
4.6|5.6|5.1|424|VIII(a) Osteosarcomas|83280391|0-19|All Races|Male and Female|2009|4.6|5.6|5.1
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
2.6|3.3|2.9|244|VIII(c) Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009|2.6|3.3|2.9
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
0.1|0.3|0.2|18|VIII(e) Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.3|0.2
10.8|12.2|11.5|989|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|0-19|All Races|Male and Female|2009|11.1|12.6|11.9
1.4|2.0|1.7|140|X(a) Intracranial & intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.4|2.0|1.7
1.1|1.6|1.4|115|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.1|1.7|1.4
7.0|8.1|7.5|653|X(c) Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|7.3|8.5|7.8
0.5|0.8|0.6|53|X(d) Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.8|0.6
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
17.3|19.1|18.2|1564|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|0-19|All Races|Male and Female|2009|17.9|19.7|18.8
0.2|0.4|0.2|21|XI(a) Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
7.6|8.8|8.2|709|XI(b) Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009|7.9|9.2|8.5
0.5|0.9|0.7|59|XI(c) Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.9|0.7
4.0|4.9|4.5|385|XI(d) Malignant melanomas|83280391|0-19|All Races|Male and Female|2009|4.2|5.1|4.6
~|~|~|~|XI(e) Skin carcinomas|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.0|4.9|4.4|382|XI(f) Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
0.7|1.1|0.9|77|XII Other and unspecified malignant neoplasms|83280391|0-19|All Races|Male and Female|2009|0.7|1.2|0.9
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.4
0.4|0.7|0.6|47|XII(b) Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
179.1|181.6|180.3|74444|All ICCC Groups Combined|410461980|0-19|All Races|Male and Female|2009-2013|180.1|182.7|181.4
46.8|48.1|47.4|19485|I Leukemias, myeloproliferative & myelodysplastic diseases|410461980|0-19|All Races|Male and Female|2009-2013|46.8|48.1|47.5
33.4|34.5|34.0|13923|I(a) Lymphoid leukemias|410461980|0-19|All Races|Male and Female|2009-2013|33.4|34.5|33.9
7.8|8.3|8.0|3319|I(b) Acute myeloid leukemias|410461980|0-19|All Races|Male and Female|2009-2013|7.8|8.4|8.1
2.2|2.5|2.3|975|I(c) Chronic myeloproliferative diseases|410461980|0-19|All Races|Male and Female|2009-2013|2.2|2.5|2.4
1.4|1.6|1.5|619|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|410461980|0-19|All Races|Male and Female|2009-2013|1.4|1.6|1.5
1.5|1.7|1.6|649|I(e) Unspecified and other specified leukemias|410461980|0-19|All Races|Male and Female|2009-2013|1.5|1.7|1.6
27.0|28.0|27.5|11404|II Lymphomas and reticuloendothelial neoplasms|410461980|0-19|All Races|Male and Female|2009-2013|27.3|28.3|27.8
11.7|12.4|12.1|5055|II(a) Hodgkin lymphomas|410461980|0-19|All Races|Male and Female|2009-2013|12.0|12.7|12.3
8.6|9.2|8.9|3682|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|410461980|0-19|All Races|Male and Female|2009-2013|8.7|9.3|9.0
2.2|2.5|2.3|961|II(c) Burkitt lymphoma|410461980|0-19|All Races|Male and Female|2009-2013|2.2|2.5|2.3
3.6|4.0|3.8|1560|II(d) Miscellaneous lymphoreticular neoplasms|410461980|0-19|All Races|Male and Female|2009-2013|3.6|4.0|3.8
0.3|0.4|0.4|146|II(e) Unspecified lymphomas|410461980|0-19|All Races|Male and Female|2009-2013|0.3|0.4|0.4
31.2|32.3|31.8|13015|III CNS and misc intracranial and intraspinal neoplasms|410461980|0-19|All Races|Male and Female|2009-2013|31.2|32.3|31.7
2.5|2.8|2.7|1093|III(a) Ependymomas and choroid plexus tumor|410461980|0-19|All Races|Male and Female|2009-2013|2.5|2.8|2.7
16.2|17.0|16.6|6788|III(b) Astrocytomas|410461980|0-19|All Races|Male and Female|2009-2013|16.1|16.9|16.5
5.8|6.2|6.0|2447|III(c) Intracranial and intraspinal embryonal tumors|410461980|0-19|All Races|Male and Female|2009-2013|5.7|6.2|6.0
5.3|5.7|5.5|2256|III(d) Other gliomas|410461980|0-19|All Races|Male and Female|2009-2013|5.3|5.7|5.5
0.5|0.7|0.6|240|III(e) Other specified intracranial & intraspinal neoplasms|410461980|0-19|All Races|Male and Female|2009-2013|0.5|0.7|0.6
0.4|0.5|0.5|191|III(f) Unspecified intracranial and intraspinal neoplasms|410461980|0-19|All Races|Male and Female|2009-2013|0.4|0.5|0.5
8.3|8.9|8.6|3536|IV Neuroblastoma and other peripheral nervous cell tumors|410461980|0-19|All Races|Male and Female|2009-2013|8.3|8.9|8.6
8.1|8.7|8.4|3438|IV(a) Neuroblastoma and ganglioneuroblastoma|410461980|0-19|All Races|Male and Female|2009-2013|8.1|8.7|8.4
0.2|0.3|0.2|98|IV(b) Other peripheral nervous cell tumors|410461980|0-19|All Races|Male and Female|2009-2013|0.2|0.3|0.2
11.7|12.4|12.0|4967|IX Soft tissue and other extraosseous sarcomas|410461980|0-19|All Races|Male and Female|2009-2013|11.8|12.4|12.1
4.5|4.9|4.7|1928|IX(a) Rhabdomyosarcomas|410461980|0-19|All Races|Male and Female|2009-2013|4.5|4.9|4.7
1.2|1.4|1.3|520|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|410461980|0-19|All Races|Male and Female|2009-2013|1.2|1.4|1.3
0.0|0.1|0.1|25|IX(c) Kaposi sarcoma|410461980|0-19|All Races|Male and Female|2009-2013|0.0|0.1|0.1
4.4|4.9|4.6|1920|IX(d) Other specified soft tissue sarcomas|410461980|0-19|All Races|Male and Female|2009-2013|4.5|4.9|4.7
1.3|1.5|1.4|574|IX(e) Unspecified soft tissue sarcomas|410461980|0-19|All Races|Male and Female|2009-2013|1.3|1.5|1.4
0.2|0.4|0.3|123|Not classified by ICCC|410461980|0-19|All Races|Male and Female|2009-2013|0.2|0.4|0.3
3.1|3.4|3.3|1336|V Retinoblastoma|410461980|0-19|All Races|Male and Female|2009-2013|3.1|3.4|3.3
6.8|7.4|7.1|2912|VI Renal tumors|410461980|0-19|All Races|Male and Female|2009-2013|6.8|7.4|7.1
6.1|6.6|6.4|2604|VI(a) Nephroblastoma and other nonepithelial renal tumors|410461980|0-19|All Races|Male and Female|2009-2013|6.1|6.6|6.3
0.6|0.8|0.7|294|VI(b) Renal carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|0.6|0.8|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|410461980|0-19|All Races|Male and Female|2009-2013|~|~|~
2.3|2.6|2.5|1017|VII Hepatic tumors|410461980|0-19|All Races|Male and Female|2009-2013|2.3|2.6|2.5
1.7|2.0|1.8|758|VII(a) Hepatoblastoma|410461980|0-19|All Races|Male and Female|2009-2013|1.7|2.0|1.8
0.5|0.7|0.6|249|VII(b) Hepatic carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|410461980|0-19|All Races|Male and Female|2009-2013|~|~|~
8.6|9.1|8.8|3644|VIII Malignant bone tumors|410461980|0-19|All Races|Male and Female|2009-2013|8.6|9.2|8.9
4.8|5.2|5.0|2056|VIII(a) Osteosarcomas|410461980|0-19|All Races|Male and Female|2009-2013|4.8|5.2|5.0
0.3|0.4|0.3|131|VIII(b) Chondrosarcomas|410461980|0-19|All Races|Male and Female|2009-2013|0.3|0.4|0.3
2.8|3.1|2.9|1203|VIII(c) Ewing tumor and related sarcomas of bone|410461980|0-19|All Races|Male and Female|2009-2013|2.8|3.1|2.9
0.4|0.5|0.4|173|VIII(d) Other specified malignant bone tumors|410461980|0-19|All Races|Male and Female|2009-2013|0.4|0.5|0.4
0.2|0.2|0.2|81|VIII(e) Unspecified malignant bone tumors|410461980|0-19|All Races|Male and Female|2009-2013|0.2|0.2|0.2
11.0|11.7|11.4|4766|X Germ cell, trophoblastic tumors & neoplasms of gonads|410461980|0-19|All Races|Male and Female|2009-2013|11.3|11.9|11.6
1.6|1.9|1.8|725|X(a) Intracranial & intraspinal germ cell tumors|410461980|0-19|All Races|Male and Female|2009-2013|1.6|1.9|1.8
1.3|1.5|1.4|580|X(b) Malignant extracranial & extragonadal germ cell tumors|410461980|0-19|All Races|Male and Female|2009-2013|1.3|1.5|1.4
7.1|7.6|7.4|3113|X(c) Malignant gonadal germ cell tumors|410461980|0-19|All Races|Male and Female|2009-2013|7.3|7.9|7.6
0.4|0.6|0.5|203|X(d) Gonadal carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|0.4|0.6|0.5
0.3|0.4|0.3|145|X(e) Other and unspecified malignant gonadal tumors|410461980|0-19|All Races|Male and Female|2009-2013|0.3|0.4|0.4
18.4|19.2|18.8|7903|XI Other malignant epithelial neoplasms and malignant melanomas|410461980|0-19|All Races|Male and Female|2009-2013|18.8|19.7|19.3
0.2|0.3|0.2|95|XI(a) Adrenocortical carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|0.2|0.3|0.2
8.7|9.3|9.0|3776|XI(b) Thyroid carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|8.9|9.5|9.2
0.5|0.7|0.6|250|XI(c) Nasopharyngeal carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|0.5|0.7|0.6
4.1|4.5|4.3|1790|XI(d) Malignant melanomas|410461980|0-19|All Races|Male and Female|2009-2013|4.2|4.6|4.4
0.1|0.1|0.1|36|XI(e) Skin carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|0.1|0.1|0.1
4.5|4.9|4.7|1956|XI(f) Other and unspecified carcinomas|410461980|0-19|All Races|Male and Female|2009-2013|4.6|5.0|4.8
0.7|0.9|0.8|336|XII Other and unspecified malignant neoplasms|410461980|0-19|All Races|Male and Female|2009-2013|0.7|0.9|0.8
0.3|0.4|0.4|157|XII(a) Other specified malignant tumors|410461980|0-19|All Races|Male and Female|2009-2013|0.3|0.4|0.4
0.4|0.5|0.4|179|XII(b) Other unspecified malignant tumors|410461980|0-19|All Races|Male and Female|2009-2013|0.4|0.5|0.4
177.7|183.5|180.6|15120|All ICCC Groups Combined|83185431|0-19|All Races|Male and Female|2010|178.9|184.7|181.8
47.3|50.4|48.8|4064|I Leukemias, myeloproliferative & myelodysplastic diseases|83185431|0-19|All Races|Male and Female|2010|47.4|50.4|48.9
33.2|35.8|34.5|2862|I(a) Lymphoid leukemias|83185431|0-19|All Races|Male and Female|2010|33.2|35.7|34.4
7.7|9.0|8.4|700|I(b) Acute myeloid leukemias|83185431|0-19|All Races|Male and Female|2010|7.8|9.1|8.4
2.3|3.0|2.6|219|I(c) Chronic myeloproliferative diseases|83185431|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
1.5|2.1|1.8|151|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83185431|0-19|All Races|Male and Female|2010|1.5|2.1|1.8
1.3|1.9|1.6|132|I(e) Unspecified and other specified leukemias|83185431|0-19|All Races|Male and Female|2010|1.3|1.9|1.6
26.3|28.6|27.4|2310|II Lymphomas and reticuloendothelial neoplasms|83185431|0-19|All Races|Male and Female|2010|26.6|28.9|27.8
11.3|12.8|12.0|1028|II(a) Hodgkin lymphomas|83185431|0-19|All Races|Male and Female|2010|11.6|13.1|12.4
8.1|9.4|8.7|729|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83185431|0-19|All Races|Male and Female|2010|8.1|9.4|8.8
2.1|2.8|2.4|202|II(c) Burkitt lymphoma|83185431|0-19|All Races|Male and Female|2010|2.1|2.8|2.4
3.5|4.3|3.9|322|II(d) Miscellaneous lymphoreticular neoplasms|83185431|0-19|All Races|Male and Female|2010|3.5|4.3|3.9
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83185431|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
30.6|33.0|31.8|2634|III CNS and misc intracranial and intraspinal neoplasms|83185431|0-19|All Races|Male and Female|2010|30.5|32.9|31.7
2.4|3.2|2.8|233|III(a) Ependymomas and choroid plexus tumor|83185431|0-19|All Races|Male and Female|2010|2.5|3.2|2.8
15.7|17.4|16.5|1371|III(b) Astrocytomas|83185431|0-19|All Races|Male and Female|2010|15.6|17.4|16.5
5.5|6.6|6.0|500|III(c) Intracranial and intraspinal embryonal tumors|83185431|0-19|All Races|Male and Female|2010|5.5|6.6|6.0
5.0|6.0|5.5|453|III(d) Other gliomas|83185431|0-19|All Races|Male and Female|2010|5.0|6.0|5.4
0.4|0.8|0.6|50|III(e) Other specified intracranial & intraspinal neoplasms|83185431|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
0.2|0.5|0.3|27|III(f) Unspecified intracranial and intraspinal neoplasms|83185431|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
7.9|9.2|8.6|711|IV Neuroblastoma and other peripheral nervous cell tumors|83185431|0-19|All Races|Male and Female|2010|7.9|9.2|8.5
7.7|9.0|8.4|694|IV(a) Neuroblastoma and ganglioneuroblastoma|83185431|0-19|All Races|Male and Female|2010|7.7|9.0|8.3
0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|83185431|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
12.0|13.5|12.7|1065|IX Soft tissue and other extraosseous sarcomas|83185431|0-19|All Races|Male and Female|2010|12.0|13.6|12.8
4.8|5.8|5.3|437|IX(a) Rhabdomyosarcomas|83185431|0-19|All Races|Male and Female|2010|4.8|5.8|5.3
0.8|1.2|1.0|84|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83185431|0-19|All Races|Male and Female|2010|0.8|1.3|1.0
~|~|~|~|IX(c) Kaposi sarcoma|83185431|0-19|All Races|Male and Female|2010|~|~|~
4.3|5.2|4.7|398|IX(d) Other specified soft tissue sarcomas|83185431|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
1.4|2.0|1.7|143|IX(e) Unspecified soft tissue sarcomas|83185431|0-19|All Races|Male and Female|2010|1.4|2.0|1.7
0.2|0.4|0.3|21|Not classified by ICCC|83185431|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
3.0|3.8|3.3|277|V Retinoblastoma|83185431|0-19|All Races|Male and Female|2010|2.9|3.7|3.3
6.1|7.3|6.7|555|VI Renal tumors|83185431|0-19|All Races|Male and Female|2010|6.1|7.3|6.7
5.6|6.7|6.1|511|VI(a) Nephroblastoma and other nonepithelial renal tumors|83185431|0-19|All Races|Male and Female|2010|5.6|6.7|6.1
0.4|0.7|0.5|42|VI(b) Renal carcinomas|83185431|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|83185431|0-19|All Races|Male and Female|2010|~|~|~
2.3|3.0|2.6|220|VII Hepatic tumors|83185431|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
1.6|2.2|1.9|159|VII(a) Hepatoblastoma|83185431|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
0.5|0.9|0.7|59|VII(b) Hepatic carcinomas|83185431|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83185431|0-19|All Races|Male and Female|2010|~|~|~
7.7|8.9|8.3|694|VIII Malignant bone tumors|83185431|0-19|All Races|Male and Female|2010|7.7|9.0|8.3
4.3|5.2|4.7|396|VIII(a) Osteosarcomas|83185431|0-19|All Races|Male and Female|2010|4.3|5.3|4.8
0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|83185431|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
2.3|3.0|2.6|216|VIII(c) Ewing tumor and related sarcomas of bone|83185431|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
0.3|0.6|0.4|36|VIII(d) Other specified malignant bone tumors|83185431|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|83185431|0-19|All Races|Male and Female|2010|~|~|~
10.8|12.3|11.5|980|X Germ cell, trophoblastic tumors & neoplasms of gonads|83185431|0-19|All Races|Male and Female|2010|11.1|12.5|11.8
1.7|2.3|2.0|167|X(a) Intracranial & intraspinal germ cell tumors|83185431|0-19|All Races|Male and Female|2010|1.7|2.3|2.0
1.1|1.6|1.3|111|X(b) Malignant extracranial & extragonadal germ cell tumors|83185431|0-19|All Races|Male and Female|2010|1.1|1.6|1.3
6.7|7.9|7.3|624|X(c) Malignant gonadal germ cell tumors|83185431|0-19|All Races|Male and Female|2010|6.9|8.1|7.5
0.4|0.7|0.5|44|X(d) Gonadal carcinomas|83185431|0-19|All Races|Male and Female|2010|0.4|0.7|0.5
0.3|0.6|0.4|34|X(e) Other and unspecified malignant gonadal tumors|83185431|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
17.0|18.8|17.9|1529|XI Other malignant epithelial neoplasms and malignant melanomas|83185431|0-19|All Races|Male and Female|2010|17.5|19.3|18.4
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83185431|0-19|All Races|Male and Female|2010|0.1|0.4|0.2
7.9|9.1|8.5|728|XI(b) Thyroid carcinomas|83185431|0-19|All Races|Male and Female|2010|8.1|9.4|8.8
0.4|0.8|0.6|49|XI(c) Nasopharyngeal carcinomas|83185431|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
3.6|4.5|4.1|347|XI(d) Malignant melanomas|83185431|0-19|All Races|Male and Female|2010|3.7|4.6|4.2
~|~|~|~|XI(e) Skin carcinomas|83185431|0-19|All Races|Male and Female|2010|~|~|~
4.0|4.9|4.4|376|XI(f) Other and unspecified carcinomas|83185431|0-19|All Races|Male and Female|2010|4.1|5.0|4.5
0.5|0.9|0.7|60|XII Other and unspecified malignant neoplasms|83185431|0-19|All Races|Male and Female|2010|0.6|0.9|0.7
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|83185431|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
0.2|0.5|0.3|28|XII(b) Other unspecified malignant tumors|83185431|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
178.9|184.7|181.8|15011|All ICCC Groups Combined|82115497|0-19|All Races|Male and Female|2011|179.9|185.8|182.8
47.2|50.3|48.7|4005|I Leukemias, myeloproliferative & myelodysplastic diseases|82115497|0-19|All Races|Male and Female|2011|47.3|50.3|48.8
34.2|36.7|35.4|2907|I(a) Lymphoid leukemias|82115497|0-19|All Races|Male and Female|2011|34.1|36.7|35.4
7.7|8.9|8.3|684|I(b) Acute myeloid leukemias|82115497|0-19|All Races|Male and Female|2011|7.7|9.0|8.3
1.9|2.6|2.3|187|I(c) Chronic myeloproliferative diseases|82115497|0-19|All Races|Male and Female|2011|2.0|2.6|2.3
1.0|1.5|1.3|104|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82115497|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
1.2|1.8|1.5|123|I(e) Unspecified and other specified leukemias|82115497|0-19|All Races|Male and Female|2011|1.2|1.8|1.5
26.4|28.7|27.6|2286|II Lymphomas and reticuloendothelial neoplasms|82115497|0-19|All Races|Male and Female|2011|26.7|29.0|27.8
11.1|12.6|11.8|989|II(a) Hodgkin lymphomas|82115497|0-19|All Races|Male and Female|2011|11.3|12.8|12.0
7.8|9.0|8.4|693|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82115497|0-19|All Races|Male and Female|2011|7.8|9.1|8.4
2.2|2.9|2.5|203|II(c) Burkitt lymphoma|82115497|0-19|All Races|Male and Female|2011|2.1|2.8|2.5
4.1|5.1|4.6|373|II(d) Miscellaneous lymphoreticular neoplasms|82115497|0-19|All Races|Male and Female|2011|4.1|5.0|4.5
0.2|0.5|0.3|28|II(e) Unspecified lymphomas|82115497|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
31.2|33.6|32.4|2655|III CNS and misc intracranial and intraspinal neoplasms|82115497|0-19|All Races|Male and Female|2011|31.1|33.6|32.3
2.5|3.2|2.8|233|III(a) Ependymomas and choroid plexus tumor|82115497|0-19|All Races|Male and Female|2011|2.5|3.2|2.8
15.9|17.6|16.7|1373|III(b) Astrocytomas|82115497|0-19|All Races|Male and Female|2011|15.8|17.6|16.7
5.6|6.6|6.1|499|III(c) Intracranial and intraspinal embryonal tumors|82115497|0-19|All Races|Male and Female|2011|5.6|6.6|6.1
5.2|6.3|5.7|470|III(d) Other gliomas|82115497|0-19|All Races|Male and Female|2011|5.2|6.3|5.7
0.4|0.7|0.5|44|III(e) Other specified intracranial & intraspinal neoplasms|82115497|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|82115497|0-19|All Races|Male and Female|2011|0.3|0.6|0.4
7.9|9.2|8.5|698|IV Neuroblastoma and other peripheral nervous cell tumors|82115497|0-19|All Races|Male and Female|2011|7.9|9.2|8.5
7.7|8.9|8.3|678|IV(a) Neuroblastoma and ganglioneuroblastoma|82115497|0-19|All Races|Male and Female|2011|7.6|8.9|8.3
0.1|0.4|0.2|20|IV(b) Other peripheral nervous cell tumors|82115497|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
11.3|12.8|12.0|993|IX Soft tissue and other extraosseous sarcomas|82115497|0-19|All Races|Male and Female|2011|11.4|12.9|12.1
4.2|5.2|4.7|384|IX(a) Rhabdomyosarcomas|82115497|0-19|All Races|Male and Female|2011|4.2|5.2|4.7
1.0|1.5|1.3|105|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82115497|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82115497|0-19|All Races|Male and Female|2011|~|~|~
4.3|5.2|4.7|393|IX(d) Other specified soft tissue sarcomas|82115497|0-19|All Races|Male and Female|2011|4.3|5.3|4.8
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82115497|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
0.2|0.5|0.3|26|Not classified by ICCC|82115497|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
2.7|3.5|3.1|256|V Retinoblastoma|82115497|0-19|All Races|Male and Female|2011|2.7|3.5|3.1
6.6|7.8|7.2|593|VI Renal tumors|82115497|0-19|All Races|Male and Female|2011|6.7|7.8|7.2
6.0|7.1|6.5|536|VI(a) Nephroblastoma and other nonepithelial renal tumors|82115497|0-19|All Races|Male and Female|2011|6.0|7.1|6.5
0.5|0.9|0.7|56|VI(b) Renal carcinomas|82115497|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82115497|0-19|All Races|Male and Female|2011|~|~|~
2.2|2.9|2.6|212|VII Hepatic tumors|82115497|0-19|All Races|Male and Female|2011|2.2|3.0|2.6
1.7|2.3|2.0|165|VII(a) Hepatoblastoma|82115497|0-19|All Races|Male and Female|2011|1.7|2.3|2.0
0.4|0.7|0.5|43|VII(b) Hepatic carcinomas|82115497|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82115497|0-19|All Races|Male and Female|2011|~|~|~
8.3|9.6|8.9|736|VIII Malignant bone tumors|82115497|0-19|All Races|Male and Female|2011|8.3|9.6|9.0
4.6|5.6|5.1|418|VIII(a) Osteosarcomas|82115497|0-19|All Races|Male and Female|2011|4.6|5.6|5.1
0.2|0.4|0.3|21|VIII(b) Chondrosarcomas|82115497|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
2.8|3.6|3.2|260|VIII(c) Ewing tumor and related sarcomas of bone|82115497|0-19|All Races|Male and Female|2011|2.8|3.6|3.2
0.2|0.4|0.3|25|VIII(d) Other specified malignant bone tumors|82115497|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82115497|0-19|All Races|Male and Female|2011|~|~|~
10.0|11.4|10.7|898|X Germ cell, trophoblastic tumors & neoplasms of gonads|82115497|0-19|All Races|Male and Female|2011|10.2|11.7|10.9
1.4|2.0|1.7|138|X(a) Intracranial & intraspinal germ cell tumors|82115497|0-19|All Races|Male and Female|2011|1.4|2.0|1.7
1.1|1.6|1.4|113|X(b) Malignant extracranial & extragonadal germ cell tumors|82115497|0-19|All Races|Male and Female|2011|1.1|1.7|1.4
6.6|7.7|7.1|600|X(c) Malignant gonadal germ cell tumors|82115497|0-19|All Races|Male and Female|2011|6.7|7.9|7.3
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82115497|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.4|0.3|21|X(e) Other and unspecified malignant gonadal tumors|82115497|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
18.1|20.0|19.0|1596|XI Other malignant epithelial neoplasms and malignant melanomas|82115497|0-19|All Races|Male and Female|2011|18.5|20.4|19.4
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|82115497|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
8.6|9.9|9.2|776|XI(b) Thyroid carcinomas|82115497|0-19|All Races|Male and Female|2011|8.8|10.1|9.5
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82115497|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
3.9|4.8|4.3|364|XI(d) Malignant melanomas|82115497|0-19|All Races|Male and Female|2011|4.0|4.9|4.4
~|~|~|~|XI(e) Skin carcinomas|82115497|0-19|All Races|Male and Female|2011|~|~|~
4.0|5.0|4.5|377|XI(f) Other and unspecified carcinomas|82115497|0-19|All Races|Male and Female|2011|4.1|5.1|4.6
0.5|0.9|0.7|57|XII Other and unspecified malignant neoplasms|82115497|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
0.2|0.5|0.3|27|XII(a) Other specified malignant tumors|82115497|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|82115497|0-19|All Races|Male and Female|2011|0.2|0.5|0.4
179.3|185.2|182.2|14972|All ICCC Groups Combined|81779507|0-19|All Races|Male and Female|2012|180.2|186.0|183.1
45.6|48.6|47.0|3852|I Leukemias, myeloproliferative & myelodysplastic diseases|81779507|0-19|All Races|Male and Female|2012|45.6|48.6|47.1
32.4|35.0|33.7|2755|I(a) Lymphoid leukemias|81779507|0-19|All Races|Male and Female|2012|32.4|35.0|33.7
7.2|8.5|7.8|643|I(b) Acute myeloid leukemias|81779507|0-19|All Races|Male and Female|2012|7.3|8.5|7.9
2.0|2.6|2.3|189|I(c) Chronic myeloproliferative diseases|81779507|0-19|All Races|Male and Female|2012|2.0|2.7|2.3
1.2|1.8|1.5|120|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81779507|0-19|All Races|Male and Female|2012|1.2|1.8|1.5
1.5|2.1|1.8|145|I(e) Unspecified and other specified leukemias|81779507|0-19|All Races|Male and Female|2012|1.5|2.1|1.8
28.3|30.7|29.5|2430|II Lymphomas and reticuloendothelial neoplasms|81779507|0-19|All Races|Male and Female|2012|28.5|30.9|29.7
11.7|13.2|12.4|1030|II(a) Hodgkin lymphomas|81779507|0-19|All Races|Male and Female|2012|11.8|13.4|12.6
9.1|10.4|9.7|799|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81779507|0-19|All Races|Male and Female|2012|9.1|10.5|9.8
2.0|2.7|2.3|188|II(c) Burkitt lymphoma|81779507|0-19|All Races|Male and Female|2012|2.0|2.7|2.3
4.2|5.1|4.6|376|II(d) Miscellaneous lymphoreticular neoplasms|81779507|0-19|All Races|Male and Female|2012|4.1|5.1|4.6
0.3|0.6|0.5|37|II(e) Unspecified lymphomas|81779507|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
30.2|32.7|31.4|2566|III CNS and misc intracranial and intraspinal neoplasms|81779507|0-19|All Races|Male and Female|2012|30.2|32.6|31.4
2.3|3.0|2.7|218|III(a) Ependymomas and choroid plexus tumor|81779507|0-19|All Races|Male and Female|2012|2.3|3.0|2.7
15.9|17.7|16.7|1368|III(b) Astrocytomas|81779507|0-19|All Races|Male and Female|2012|15.9|17.6|16.7
5.3|6.4|5.8|477|III(c) Intracranial and intraspinal embryonal tumors|81779507|0-19|All Races|Male and Female|2012|5.3|6.4|5.8
4.5|5.5|5.0|410|III(d) Other gliomas|81779507|0-19|All Races|Male and Female|2012|4.5|5.5|5.0
0.4|0.7|0.5|42|III(e) Other specified intracranial & intraspinal neoplasms|81779507|0-19|All Races|Male and Female|2012|0.4|0.7|0.5
0.5|0.8|0.6|51|III(f) Unspecified intracranial and intraspinal neoplasms|81779507|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
8.0|9.3|8.6|703|IV Neuroblastoma and other peripheral nervous cell tumors|81779507|0-19|All Races|Male and Female|2012|8.0|9.3|8.6
7.8|9.0|8.4|684|IV(a) Neuroblastoma and ganglioneuroblastoma|81779507|0-19|All Races|Male and Female|2012|7.7|9.0|8.4
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|81779507|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
10.9|12.4|11.6|952|IX Soft tissue and other extraosseous sarcomas|81779507|0-19|All Races|Male and Female|2012|10.9|12.4|11.6
4.1|5.0|4.5|369|IX(a) Rhabdomyosarcomas|81779507|0-19|All Races|Male and Female|2012|4.1|5.0|4.5
1.0|1.5|1.2|101|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81779507|0-19|All Races|Male and Female|2012|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|81779507|0-19|All Races|Male and Female|2012|~|~|~
4.0|4.9|4.4|362|IX(d) Other specified soft tissue sarcomas|81779507|0-19|All Races|Male and Female|2012|4.0|4.9|4.4
1.1|1.7|1.4|114|IX(e) Unspecified soft tissue sarcomas|81779507|0-19|All Races|Male and Female|2012|1.1|1.7|1.4
0.1|0.4|0.2|20|Not classified by ICCC|81779507|0-19|All Races|Male and Female|2012|0.1|0.4|0.2
2.9|3.7|3.2|265|V Retinoblastoma|81779507|0-19|All Races|Male and Female|2012|2.9|3.7|3.2
6.4|7.6|7.0|572|VI Renal tumors|81779507|0-19|All Races|Male and Female|2012|6.4|7.6|7.0
5.7|6.8|6.2|506|VI(a) Nephroblastoma and other nonepithelial renal tumors|81779507|0-19|All Races|Male and Female|2012|5.7|6.8|6.2
0.6|0.9|0.7|60|VI(b) Renal carcinomas|81779507|0-19|All Races|Male and Female|2012|0.6|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|81779507|0-19|All Races|Male and Female|2012|~|~|~
2.4|3.1|2.8|226|VII Hepatic tumors|81779507|0-19|All Races|Male and Female|2012|2.4|3.1|2.8
1.8|2.5|2.1|174|VII(a) Hepatoblastoma|81779507|0-19|All Races|Male and Female|2012|1.8|2.5|2.1
0.5|0.8|0.6|50|VII(b) Hepatic carcinomas|81779507|0-19|All Races|Male and Female|2012|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81779507|0-19|All Races|Male and Female|2012|~|~|~
8.3|9.6|8.9|732|VIII Malignant bone tumors|81779507|0-19|All Races|Male and Female|2012|8.3|9.6|9.0
4.7|5.7|5.2|424|VIII(a) Osteosarcomas|81779507|0-19|All Races|Male and Female|2012|4.7|5.7|5.2
0.2|0.5|0.3|27|VIII(b) Chondrosarcomas|81779507|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
2.4|3.2|2.8|228|VIII(c) Ewing tumor and related sarcomas of bone|81779507|0-19|All Races|Male and Female|2012|2.4|3.2|2.8
0.3|0.6|0.4|32|VIII(d) Other specified malignant bone tumors|81779507|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|81779507|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
10.8|12.3|11.5|956|X Germ cell, trophoblastic tumors & neoplasms of gonads|81779507|0-19|All Races|Male and Female|2012|11.0|12.5|11.7
1.3|1.9|1.6|129|X(a) Intracranial & intraspinal germ cell tumors|81779507|0-19|All Races|Male and Female|2012|1.3|1.9|1.6
1.4|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|81779507|0-19|All Races|Male and Female|2012|1.4|1.9|1.6
7.0|8.2|7.5|630|X(c) Malignant gonadal germ cell tumors|81779507|0-19|All Races|Male and Female|2012|7.1|8.3|7.7
0.3|0.6|0.4|35|X(d) Gonadal carcinomas|81779507|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|81779507|0-19|All Races|Male and Female|2012|0.2|0.5|0.3
18.6|20.5|19.5|1623|XI Other malignant epithelial neoplasms and malignant melanomas|81779507|0-19|All Races|Male and Female|2012|18.9|20.8|19.8
0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|81779507|0-19|All Races|Male and Female|2012|0.2|0.4|0.3
9.0|10.3|9.6|801|XI(b) Thyroid carcinomas|81779507|0-19|All Races|Male and Female|2012|9.1|10.5|9.8
0.3|0.6|0.5|38|XI(c) Nasopharyngeal carcinomas|81779507|0-19|All Races|Male and Female|2012|0.3|0.6|0.5
3.8|4.7|4.2|351|XI(d) Malignant melanomas|81779507|0-19|All Races|Male and Female|2012|3.9|4.8|4.3
~|~|~|~|XI(e) Skin carcinomas|81779507|0-19|All Races|Male and Female|2012|~|~|~
4.4|5.3|4.8|403|XI(f) Other and unspecified carcinomas|81779507|0-19|All Races|Male and Female|2012|4.5|5.4|4.9
0.7|1.1|0.9|75|XII Other and unspecified malignant neoplasms|81779507|0-19|All Races|Male and Female|2012|0.7|1.1|0.9
0.3|0.5|0.4|32|XII(a) Other specified malignant tumors|81779507|0-19|All Races|Male and Female|2012|0.3|0.6|0.4
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|81779507|0-19|All Races|Male and Female|2012|0.4|0.7|0.5
177.1|183.0|180.0|14728|All ICCC Groups Combined|81571493|0-19|All Races|Male and Female|2013|177.6|183.5|180.6
44.3|47.3|45.8|3734|I Leukemias, myeloproliferative & myelodysplastic diseases|81571493|0-19|All Races|Male and Female|2013|44.3|47.3|45.8
30.7|33.2|31.9|2601|I(a) Lymphoid leukemias|81571493|0-19|All Races|Male and Female|2013|30.7|33.1|31.9
7.5|8.8|8.1|664|I(b) Acute myeloid leukemias|81571493|0-19|All Races|Male and Female|2013|7.5|8.8|8.1
2.0|2.6|2.3|188|I(c) Chronic myeloproliferative diseases|81571493|0-19|All Races|Male and Female|2013|2.0|2.7|2.3
1.2|1.8|1.5|122|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81571493|0-19|All Races|Male and Female|2013|1.2|1.8|1.5
1.7|2.3|2.0|159|I(e) Unspecified and other specified leukemias|81571493|0-19|All Races|Male and Female|2013|1.7|2.3|1.9
26.5|28.8|27.6|2267|II Lymphomas and reticuloendothelial neoplasms|81571493|0-19|All Races|Male and Female|2013|26.7|29.0|27.8
10.7|12.1|11.4|939|II(a) Hodgkin lymphomas|81571493|0-19|All Races|Male and Female|2013|10.8|12.3|11.5
8.2|9.6|8.9|727|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81571493|0-19|All Races|Male and Female|2013|8.3|9.6|8.9
2.0|2.7|2.3|189|II(c) Burkitt lymphoma|81571493|0-19|All Races|Male and Female|2013|2.0|2.7|2.3
4.3|5.2|4.7|385|II(d) Miscellaneous lymphoreticular neoplasms|81571493|0-19|All Races|Male and Female|2013|4.3|5.2|4.7
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81571493|0-19|All Races|Male and Female|2013|0.2|0.5|0.3
30.3|32.8|31.5|2568|III CNS and misc intracranial and intraspinal neoplasms|81571493|0-19|All Races|Male and Female|2013|30.3|32.7|31.5
2.3|3.0|2.6|211|III(a) Ependymomas and choroid plexus tumor|81571493|0-19|All Races|Male and Female|2013|2.2|3.0|2.6
16.0|17.8|16.9|1373|III(b) Astrocytomas|81571493|0-19|All Races|Male and Female|2013|16.0|17.7|16.8
5.1|6.2|5.6|457|III(c) Intracranial and intraspinal embryonal tumors|81571493|0-19|All Races|Male and Female|2013|5.1|6.1|5.6
4.8|5.8|5.3|432|III(d) Other gliomas|81571493|0-19|All Races|Male and Female|2013|4.8|5.8|5.3
0.5|0.9|0.7|56|III(e) Other specified intracranial & intraspinal neoplasms|81571493|0-19|All Races|Male and Female|2013|0.5|0.9|0.7
0.3|0.7|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|81571493|0-19|All Races|Male and Female|2013|0.3|0.7|0.5
8.5|9.8|9.1|745|IV Neuroblastoma and other peripheral nervous cell tumors|81571493|0-19|All Races|Male and Female|2013|8.5|9.8|9.1
8.2|9.5|8.9|722|IV(a) Neuroblastoma and ganglioneuroblastoma|81571493|0-19|All Races|Male and Female|2013|8.2|9.5|8.9
0.2|0.4|0.3|23|IV(b) Other peripheral nervous cell tumors|81571493|0-19|All Races|Male and Female|2013|0.2|0.4|0.3
11.0|12.5|11.7|958|IX Soft tissue and other extraosseous sarcomas|81571493|0-19|All Races|Male and Female|2013|11.0|12.5|11.7
4.3|5.3|4.8|391|IX(a) Rhabdomyosarcomas|81571493|0-19|All Races|Male and Female|2013|4.3|5.3|4.8
1.0|1.5|1.2|102|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81571493|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|81571493|0-19|All Races|Male and Female|2013|~|~|~
4.0|4.9|4.4|362|IX(d) Other specified soft tissue sarcomas|81571493|0-19|All Races|Male and Female|2013|4.0|4.9|4.4
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|81571493|0-19|All Races|Male and Female|2013|1.0|1.5|1.3
0.2|0.5|0.3|26|Not classified by ICCC|81571493|0-19|All Races|Male and Female|2013|0.2|0.5|0.3
2.8|3.6|3.2|261|V Retinoblastoma|81571493|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
6.7|7.9|7.3|592|VI Renal tumors|81571493|0-19|All Races|Male and Female|2013|6.7|7.9|7.3
5.8|6.9|6.4|519|VI(a) Nephroblastoma and other nonepithelial renal tumors|81571493|0-19|All Races|Male and Female|2013|5.8|6.9|6.4
0.7|1.1|0.8|70|VI(b) Renal carcinomas|81571493|0-19|All Races|Male and Female|2013|0.7|1.1|0.9
~|~|~|~|VI(c) Unspecified malignant renal tumors|81571493|0-19|All Races|Male and Female|2013|~|~|~
2.1|2.7|2.4|194|VII Hepatic tumors|81571493|0-19|All Races|Male and Female|2013|2.1|2.7|2.4
1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81571493|0-19|All Races|Male and Female|2013|1.5|2.1|1.8
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81571493|0-19|All Races|Male and Female|2013|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81571493|0-19|All Races|Male and Female|2013|~|~|~
8.4|9.7|9.0|736|VIII Malignant bone tumors|81571493|0-19|All Races|Male and Female|2013|8.4|9.7|9.0
4.4|5.4|4.9|399|VIII(a) Osteosarcomas|81571493|0-19|All Races|Male and Female|2013|4.4|5.4|4.9
0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|81571493|0-19|All Races|Male and Female|2013|0.2|0.5|0.3
2.8|3.6|3.2|259|VIII(c) Ewing tumor and related sarcomas of bone|81571493|0-19|All Races|Male and Female|2013|2.8|3.6|3.2
0.3|0.6|0.5|38|VIII(d) Other specified malignant bone tumors|81571493|0-19|All Races|Male and Female|2013|0.3|0.6|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81571493|0-19|All Races|Male and Female|2013|~|~|~
10.9|12.4|11.6|959|X Germ cell, trophoblastic tumors & neoplasms of gonads|81571493|0-19|All Races|Male and Female|2013|11.0|12.5|11.8
1.6|2.2|1.8|151|X(a) Intracranial & intraspinal germ cell tumors|81571493|0-19|All Races|Male and Female|2013|1.6|2.2|1.9
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|81571493|0-19|All Races|Male and Female|2013|1.1|1.6|1.3
6.9|8.1|7.5|619|X(c) Malignant gonadal germ cell tumors|81571493|0-19|All Races|Male and Female|2013|7.0|8.2|7.6
0.4|0.7|0.5|45|X(d) Gonadal carcinomas|81571493|0-19|All Races|Male and Female|2013|0.4|0.7|0.6
0.3|0.6|0.4|35|X(e) Other and unspecified malignant gonadal tumors|81571493|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
18.7|20.6|19.6|1619|XI Other malignant epithelial neoplasms and malignant melanomas|81571493|0-19|All Races|Male and Female|2013|18.9|20.8|19.8
~|~|~|~|XI(a) Adrenocortical carcinomas|81571493|0-19|All Races|Male and Female|2013|~|~|~
8.8|10.1|9.4|777|XI(b) Thyroid carcinomas|81571493|0-19|All Races|Male and Female|2013|8.9|10.2|9.5
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|81571493|0-19|All Races|Male and Female|2013|0.5|0.8|0.6
3.8|4.7|4.2|347|XI(d) Malignant melanomas|81571493|0-19|All Races|Male and Female|2013|3.8|4.7|4.3
~|~|~|~|XI(e) Skin carcinomas|81571493|0-19|All Races|Male and Female|2013|~|~|~
4.7|5.7|5.2|427|XI(f) Other and unspecified carcinomas|81571493|0-19|All Races|Male and Female|2013|4.7|5.8|5.2
0.7|1.1|0.8|69|XII Other and unspecified malignant neoplasms|81571493|0-19|All Races|Male and Female|2013|0.7|1.1|0.8
0.3|0.6|0.4|36|XII(a) Other specified malignant tumors|81571493|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
0.3|0.6|0.4|33|XII(b) Other unspecified malignant tumors|81571493|0-19|All Races|Male and Female|2013|0.3|0.6|0.4
